<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>RELB-mediated Immune Dysregulation in Behcet’s Disease</title>

<script src="report_template_files/header-attrs-2.27/header-attrs.js"></script>
<script src="report_template_files/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="report_template_files/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="report_template_files/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="report_template_files/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="report_template_files/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="report_template_files/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="report_template_files/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="report_template_files/tocify-1.9.1/jquery.tocify.js"></script>
<script src="report_template_files/navigation-1.1/tabsets.js"></script>
<link href="report_template_files/highlightjs-9.12.0/default.css" rel="stylesheet" />
<script src="report_template_files/highlightjs-9.12.0/highlight.js"></script>
<link href="report_template_files/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet" />
<script src="report_template_files/htmlwidgets-1.6.4/htmlwidgets.js"></script>
<link href="report_template_files/vis-9.1.0/vis-network.min.css" rel="stylesheet" />
<script src="report_template_files/vis-9.1.0/vis-network.min.js"></script>
<script src="report_template_files/visNetwork-binding-2.1.2/visNetwork.js"></script>
<link href="report_template_files/pagedtable-1.1/css/pagedtable.css" rel="stylesheet" />
<script src="report_template_files/pagedtable-1.1/js/pagedtable.js"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>






<link rel="stylesheet" href="styles.css" type="text/css" />



<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>



<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div id="header">



<h1 class="title toc-ignore">RELB-mediated Immune Dysregulation in
Behcet’s Disease</h1>

</div>


<div id="integrated-analysis-results" class="section level2">
<h2>1. Integrated Analysis Results</h2>
<p>This report summarizes the results of a multi-agent-AI-system (IAN)
based analysis performed using the provided list of differentially
expressed genes. Results after IAN integrated all the individual agents
responses is provided below:</p>
<div id="high-level-summary" class="section level3">
<h3>1.1. High-Level Summary</h3>
<p>Behcet’s disease pathogenesis involves a complex interplay between
peripheral and central inflammation. Peripheral immune dysregulation,
characterized by complement activation (C1QA, C1QB, C1QC, C2, CFB),
cytokine signaling, and chemokine signaling (CXCL1, CXCL5, CX3CR1), is a
primary driver. Macrophage activation (CD68) plays a crucial role. These
inflammatory processes may trigger neuroinflammation (Agent 1) and are
potentially linked to infectious triggers (Agent 2). Dysregulation of
GPCR signaling (Agent 3) and ECM remodeling further contribute. The
transcription factor RELB appears to be a central orchestrator of these
processes, regulating the expression of numerous chemokines and their
receptors. Albumin (ALB) may serve as a systemic indicator of the
inflammatory state.</p>
</div>
<div id="affected-biological-processes" class="section level3">
<h3>1.2. Affected Biological Processes</h3>
<p>Integrating the agent summaries and the provided data reveals a
consistent picture of dysregulated immune responses in BD. The core
processes implicated across all analyses are:</p>
<ul>
<li><p><strong>Complement activation:</strong> Multiple pathways (KEGG,
WikiPathways, Reactome) and GO terms consistently highlight the
involvement of complement components (C1QA, C1QB, C1QC, C2,
CFB).</p></li>
<li><p><strong>Cytokine and chemokine signaling:</strong> KEGG,
WikiPathways, Reactome, and GO analyses all show enrichment of pathways
and terms related to cytokine-cytokine receptor interactions and
chemokine-mediated signaling. Key genes include CXCL1, CXCL5, CXCR1,
CXCR2, and CX3CR1.</p></li>
<li><p><strong>Macrophage activation:</strong> CD68, a macrophage
marker, consistently appears in multiple analyses with high STRING
network scores, indicating a central role for macrophages in the
inflammatory response.</p></li>
<li><p><strong>ECM remodeling:</strong> Several pathways and GO terms
point to alterations in ECM components (COL1A1, VTN, ACAN,
COMP).</p></li>
<li><p><strong>Neuronal function (Agent 1):</strong> Agent 1 uniquely
highlights neuronal pathways, suggesting neuroinflammation.</p></li>
<li><p><strong>Infectious disease pathways (Agent 2):</strong> Agent 2
uniquely highlights pathways associated with bacterial and other
infections, suggesting a potential link between infection and BD
pathogenesis.</p></li>
<li><p><strong>GPCR signaling (Agent 3):</strong> Agent 3 uniquely
emphasizes the involvement of various GPCR signaling pathways,
potentially mediating inflammatory responses and immune cell
migration.</p></li>
</ul>
<p>The overlap genes (present in multiple pathway analyses) reinforce
the importance of these core processes. Unique genes in each analysis
suggest additional layers of complexity and specialized roles within the
overall inflammatory response.</p>
</div>
<div id="potential-regulatory-networks" class="section level3">
<h3>1.3. Potential Regulatory Networks</h3>
<p>The ChEA analysis strongly implicates RELB as a master regulator. Its
target genes (CCDC71L, PPP1R15A, ANKRD37, SPHK1, ROM1, TNFAIP3, CXCL1,
AP5B1, LTC4S, KAZALD1, CXCL5, SOCS3, DDIT4, CDC42EP2, HBEGF) are
involved in multiple enriched pathways, primarily related to immune
responses. The interactions between RELB and its target genes, many of
which are chemokines or chemokine receptors, are largely supported by
the STRING data. The novel interactions identified by ChEA (e.g.,
RELB-ANKRD37, RELB-CCDC71L) require further investigation to determine
their functional significance in BD. Besides RELB, other potential
upstream regulators include:</p>
<ul>
<li><p><strong>NF-κB:</strong> Consistently implicated across multiple
analyses due to the enrichment of TNF receptor signaling
pathways.</p></li>
<li><p><strong>AP-1 (Jun/Fos):</strong> The presence of FOSL1 and JUND,
and their interaction (high STRING score), suggests AP-1’s involvement
in regulating genes in inflammatory pathways.</p></li>
<li><p><strong>STAT family members:</strong> The strong enrichment of
cytokine pathways suggests the involvement of STAT transcription
factors.</p></li>
<li><p><strong>CEBPB:</strong> This transcription factor is consistently
implicated in multiple analyses and has high STRING network scores,
suggesting a role in regulating immune responses.</p></li>
<li><p><strong>PPARs:</strong> Agent 2 suggests a potential role for
PPARs in lipid metabolism and inflammation.</p></li>
</ul>
</div>
<div id="potential-hub-genes" class="section level3">
<h3>1.4. Potential Hub Genes</h3>
<p>Based on the integrated analysis and STRING network properties, the
following genes emerge as potential hub genes:</p>
<ul>
<li><p><strong>ALB:</strong> Highest combined network score in STRING,
involved in multiple processes (immune response, lipid metabolism,
ECM).</p></li>
<li><p><strong>CX3CR1:</strong> Enriched in multiple pathways (immune
response, neuronal function, GPCR signaling) and GO terms.</p></li>
<li><p><strong>C1QA, C1QB, C1QC:</strong> Core complement components,
enriched in multiple pathways and GO terms.</p></li>
<li><p><strong>RELB:</strong> Identified as a potential upstream
regulator by ChEA, regulating genes involved in inflammation and immune
response.</p></li>
<li><p><strong>CD68:</strong> High STRING score, central to macrophage
activation.</p></li>
<li><p><strong>CXCL1:</strong> High STRING score, key player in
chemokine signaling.</p></li>
<li><p><strong>APOE:</strong> High STRING score, involved in lipid
metabolism and inflammation.</p></li>
</ul>
<p>These genes are consistently enriched across multiple pathways and GO
terms and often exhibit high STRING network scores. Their central
positions in the STRING network further support their hub gene
status.</p>
</div>
<div id="similar-systems" class="section level3">
<h3>1.5. Similar Systems</h3>
<p>The observed pathways and interactions are similar to those reported
in other inflammatory and autoimmune diseases, including systemic lupus
erythematosus, rheumatoid arthritis, multiple sclerosis, and
inflammatory bowel disease.</p>
</div>
<div id="novelty-exploration" class="section level3">
<h3>1.6. Novelty Exploration</h3>
<p>The strong enrichment of neuronal pathways (Agent 1) in PBMCs is
potentially novel, suggesting a peripheral-central inflammation link.
The unexpected connections between complement activation and neuronal
pathways warrant further investigation. The involvement of infectious
disease pathways (Agent 2) may also represent a novel aspect of BD
pathogenesis. The extensive GPCR signaling involvement (Agent 3) also
requires further exploration.</p>
</div>
<div id="download-full-analysis-report" class="section level3">
<h3>1.7. Download Full Analysis Report</h3>
<p>Download the Full Integrated IAN Analysis Report Here:</p>
<p><a href='enrichment_results/final_response.txt'>Open full
final_response.txt text in new tab</a></p>
</div>
</div>
<div id="system-model" class="section level2">
<h2>2. System Model</h2>
<p>IAN takes the integrated full analysis report and the integrated
system network data from each of the agents response and puts forward a
system model, which includes the system overview, mechanistic model and
an hypothesis.</p>
<div id="system-model-and-overview" class="section level3">
<h3>2.1. System Model and Overview</h3>
<div class="visNetwork html-widget html-fill-item" id="htmlwidget-715d2ddbdbe5e5d0bee3" style="width:672px;height:480px;"></div>
<script type="application/json" data-for="htmlwidget-715d2ddbdbe5e5d0bee3">{"x":{"nodes":{"id":["RELB","ALB","APOE","C1QA","CX3CR1","CD68","TYROBP","SPI1","CXCL1","CXCL5","TNFAIP3","Complement Activation","Blood Vessel Diameter Maintenance","Complement Cascade","Lipid Particles Composition","Immune Response","Chemokine-Mediated Signaling Pathway","Macrophage Activation","Myeloid Leukocyte Activation","CEBPB"],"group":["Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Process","Process","Process","Process","Process","Process","Process","Process","Gene"],"label":["RELB","ALB","APOE","C1QA","CX3CR1","CD68","TYROBP","SPI1","CXCL1","CXCL5","TNFAIP3","Complement Activation","Blood Vessel Diameter Maintenance","Complement Cascade","Lipid Particles Composition","Immune Response","Chemokine-Mediated Signaling Pathway","Macrophage Activation","Myeloid Leukocyte Activation","CEBPB"]},"edges":{"from":["RELB","RELB","RELB","ALB","ALB","APOE","APOE","C1QA","CX3CR1","CD68","TYROBP","SPI1","RELB","ALB","ALB","C1QA","CX3CR1"],"to":["CXCL1","CXCL5","TNFAIP3","Complement Activation","Blood Vessel Diameter Maintenance","Complement Cascade","Lipid Particles Composition","Immune Response","Chemokine-Mediated Signaling Pathway","Macrophage Activation","Myeloid Leukocyte Activation","Myeloid Leukocyte Activation","CEBPB","APOE","CD68","CD68","CXCL1"]},"nodesToDataframe":true,"edgesToDataframe":true,"options":{"width":"100%","height":"100%","nodes":{"shape":"dot","size":20,"font":{"size":24}},"manipulation":{"enabled":false},"edges":{"arrows":"to"}},"groups":["Gene","Process"],"width":null,"height":null,"idselection":{"enabled":false,"style":"width: 150px; height: 26px","useLabels":true,"main":"Select by id"},"byselection":{"enabled":false,"style":"width: 150px; height: 26px","multiple":false,"hideColor":"rgba(200,200,200,0.5)","highlight":false},"main":null,"submain":null,"footer":null,"background":"rgba(0, 0, 0, 0)","highlight":{"enabled":true,"hoverNearest":false,"degree":1,"algorithm":"all","hideColor":"rgba(200,200,200,0.5)","labelOnly":true},"collapse":{"enabled":false,"fit":false,"resetHighlight":true,"clusterOptions":null,"keepCoord":true,"labelSuffix":"(cluster)"}},"evals":[],"jsHooks":[]}</script>
<p>The provided network depicts a complex interplay of genes and
pathways primarily involved in immune response, inflammation, complement
activation, and extracellular matrix (ECM) interactions. The
differentially expressed genes (DEGs) identified from Behcet’s disease
(BD) patients, compared to healthy controls (HC), provide crucial
context for understanding the system’s dysregulation in this autoimmune
disease. The network highlights the central roles of several key genes,
including <em>RELB</em>, <em>ALB</em>, <em>APOE</em>, <em>C1QA</em>,
<em>C1QB</em>, <em>C1QC</em>, <em>CX3CR1</em>, <em>CD68</em>,
<em>TYROBP</em>, and <em>SPI1</em>, in orchestrating these processes.
The interactions suggest a complex interplay between innate and adaptive
immunity, with potential implications for vascular function and tissue
remodeling.</p>
</div>
<div id="mechanistic-model" class="section level3">
<h3>2.2. Mechanistic Model</h3>
<p>The identified relationships suggest a mechanistic model where the
upstream regulators and key genes influence the BD phenotype through
their downstream targets and pathways. Dysregulation of <em>RELB</em>
leads to altered expression of its target genes (<em>CXCL1</em>,
<em>CXCL5</em>, <em>TNFAIP3</em>), resulting in an amplified
inflammatory response. <em>ALB</em>’s involvement in multiple pathways
suggests a contribution to vascular dysfunction and tissue damage. The
complement components (<em>C1QA</em>, <em>C1QB</em>, <em>C1QC</em>)
contribute to the inflammatory cascade through activation of the
complement system. <em>APOE</em>’s involvement links lipid metabolism to
inflammation and vascular dysfunction. <em>CX3CR1</em>, <em>CD68</em>,
<em>TYROBP</em>, and <em>SPI1</em> contribute to immune cell
recruitment, activation, and tissue remodeling. The interactions between
these genes suggest a complex interplay between innate and adaptive
immunity, leading to the characteristic inflammation and vascular
complications of BD.</p>
</div>
<div id="hypothesis" class="section level3">
<h3>2.3. Hypothesis</h3>
<p>Behcet’s disease pathogenesis involves a systemic dysregulation of
immune responses, complement activation, and ECM interactions. We
hypothesize that dysregulation of <em>RELB</em>, <em>ALB</em>,
<em>APOE</em>, and the complement system (<em>C1QA</em>, <em>C1QB</em>,
<em>C1QC</em>) leads to altered expression of their target genes and
pathways, resulting in an amplified inflammatory response, impaired
immune regulation, and altered tissue remodeling, contributing to the
development and progression of BD. The specific interactions between
these key players, particularly the interplay between inflammatory
chemokines (<em>CXCL1</em>, <em>CXCL5</em>) and immune cell activation
markers (<em>CD68</em>, <em>TYROBP</em>, <em>SPI1</em>), are crucial in
driving the disease phenotype. Further investigation into the specific
molecular mechanisms underlying the dysregulation of these genes and
pathways is needed to fully elucidate the pathogenesis of BD.</p>
</div>
<div id="download-system-model-report" class="section level3">
<h3>2.4. Download System Model Report</h3>
<p>Download the Full System Model Report Here:</p>
<p><a href='enrichment_results/system_model.txt'>Open full
system_model.txt text in new tab</a></p>
</div>
</div>
<div id="kegg-enrichment" class="section level2">
<h2>3. KEGG Enrichment</h2>
<p>IAN runs enrichment analysis, filters the significant terms, prepares
metadata and generates the LLM based agent response, analyzing the data
like a human expert.</p>
<div id="kegg-enrichment-results" class="section level3">
<h3>3.1. Kegg Enrichment Results</h3>
<p>KEGG pathway enrichment analysis results, filtered</p>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["ID"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Description"],"name":[2],"type":["chr"],"align":["left"]},{"label":["pvalue"],"name":[3],"type":["dbl"],"align":["right"]},{"label":["Gene"],"name":[4],"type":["chr"],"align":["left"]},{"label":["neglog10p"],"name":[5],"type":["dbl"],"align":["right"]}],"data":[{"1":"hsa04061","2":"Viral protein interaction with cytokine and cytokine receptor","3":"7.914180e-05","4":"CX3CR1,ACKR3,CCR9,CXCR1,CXCL5,XCR1,CCR8,CXCR2,CXCL1,CCL4L2,CCL4L1,CCL14","5":"4.101594"},{"1":"hsa04060","2":"Cytokine-cytokine receptor interaction","3":"8.245219e-05","4":"TNFSF12,IL27,RELT,IL17C,TNFRSF12A,CX3CR1,CXCL16,ACKR3,FASLG,CCR9,GDF15,CXCR1,CXCL5,XCR1,IL31RA,CCR8,CXCR2,TNFRSF17,CXCL1,CCL4L2,CCL4L1,CXCL17,CCL14","5":"4.083798"},{"1":"hsa04080","2":"Neuroactive ligand-receptor interaction","3":"1.346323e-04","4":"OGFR,AVPR2,DRD4,LPAR2,GRIN2D,GRIN1,GRIN2C,AVPR1A,GALR2,ADORA2A,P2RX2,CHRNG,P2RY2,LHB,SCT,KISS1R,CHRND,PTGER1,F2RL2,ADM,FPR3,VGF,ADRA2B,EDNRB,GCGR,HRH1","5":"3.870851"},{"1":"hsa04657","2":"IL-17 signaling pathway","3":"2.163545e-04","4":"MUC5B,FOSL1,JUND,MAPK12,IL17C,S100A8,CEBPB,TNFAIP3,CXCL5,MUC5AC,CXCL1","5":"3.664834"},{"1":"hsa04148","2":"Efferocytosis","3":"1.573348e-03","4":"GAS6,ADGRB1,SPHK1,MAPK12,ATP2A1,C1QB,CX3CR1,C1QA,C1QC,CEBPB,ATP8A2,P2RY2,CD24","5":"2.803175"},{"1":"hsa04610","2":"Complement and coagulation cascades","3":"1.963947e-03","4":"C2,C1QB,C1QA,CR2,VTN,C1QC,SERPIND1,CFB,F2RL2","5":"2.706870"},{"1":"hsa04820","2":"Cytoskeleton in muscle cells","3":"3.200694e-03","4":"FMNL1,MYL5,AGRN,MYH7B,SSPN,MYBPC3,PDLIM7,COL4A4,ITGB4,COMP,SPTBN4,SDC3,CKM,PDLIM4,COL1A1,FBN3","5":"2.494756"},{"1":"hsa04062","2":"Chemokine signaling pathway","3":"3.630618e-03","4":"PRKACB,GNG13,CX3CR1,CXCL16,CCR9,CXCR1,CXCL5,XCR1,CCR8,CXCR2,CXCL1,CCL4L2,CCL4L1,CCL14","5":"2.440019"},{"1":"hsa05120","2":"Epithelial cell signaling in Helicobacter pylori infection","3":"7.469274e-03","4":"ATP6V1F,ATP6V0C,MAPK12,CXCR1,HBEGF,CXCR2,CXCL1","5":"2.126722"},{"1":"hsa04713","2":"Circadian entrainment","3":"1.245544e-02","4":"PRKACB,GRIN2D,GRIN1,PER1,GRIN2C,GNG13,GUCY1B1,KCNJ9","5":"1.904641"},{"1":"hsa05150","2":"Staphylococcus aureus infection","3":"1.649641e-02","4":"C2,C1QB,C1QA,C1QC,FCGR1A,CFB,FPR3,DEFA1B","5":"1.782611"},{"1":"hsa04380","2":"Osteoclast differentiation","3":"1.656243e-02","4":"CYBA,FOSL1,TYROBP,SPI1,JUND,RELB,MAPK12,ATP2A1,SOCS3,FCGR1A","5":"1.780876"},{"1":"hsa04742","2":"Taste transduction","3":"2.016367e-02","4":"PRKACB,GNG13,TAS1R3,TAS2R4,P2RX2,TAS2R3,TAS2R5","5":"1.695430"},{"1":"hsa04512","2":"ECM-receptor interaction","3":"2.386334e-02","4":"AGRN,VTN,COL4A4,ITGB4,COMP,HMMR,COL1A1","5":"1.622269"},{"1":"hsa03320","2":"PPAR signaling pathway","3":"3.472237e-02","4":"PLIN4,ANGPTL4,GK3,OLR1,LPL,ACSBG2","5":"1.459391"},{"1":"hsa05133","2":"Pertussis","3":"3.871886e-02","4":"MAPK12,C2,C1QB,C1QA,C1QC,CXCL5","5":"1.412077"},{"1":"hsa04721","2":"Synaptic vesicle cycle","3":"4.082249e-02","4":"ATP6V1F,ATP6V0C,DNM3,CPLX1,CPLX2,SLC1A2","5":"1.389100"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="kegg-enrichment-analysis-plot" class="section level3">
<h3>3.2. Kegg Enrichment Analysis Plot</h3>
<p>KEGG pathway enrichment analysis results, filtered - plot</p>
<p><img src="report_template_files/figure-html/kegg_filtered_plot-1.png" width="768" /><a href='kegg_enrichment_plot.png' download>Download
Plot as PNG</a></p>
</div>
<div id="kegg-llm-agent-response" class="section level3">
<h3>3.3. KEGG LLM Agent Response</h3>
<p>Agent 2: <strong>1. Summary and Categorization:</strong></p>
<p>The significantly enriched KEGG pathways in this Behcet’s disease
(BD) transcriptomics study primarily highlight dysregulation of immune
responses and cell signaling. Specifically, pathways related to
cytokine-cytokine receptor interactions, chemokine signaling, IL-17
signaling, and complement and coagulation cascades show strong
enrichment. These findings suggest a complex inflammatory process
involving multiple immune cell types and signaling molecules.</p>
<p><strong>Categorization:</strong></p>
<ul>
<li><strong>Immune Response:</strong> Cytokine-cytokine receptor
interaction, Viral protein interaction with cytokine and cytokine
receptor, IL-17 signaling pathway, Complement and coagulation cascades
(4 pathways)</li>
<li><strong>Cell Signaling:</strong> PPAR signaling pathway, Chemokine
signaling pathway, Neuroactive ligand-receptor interaction (3
pathways)</li>
<li><strong>Muscle and ECM:</strong> Osteoclast differentiation,
ECM-receptor interaction, Cytoskeleton in muscle cells (3 pathways)</li>
<li><strong>Other:</strong> Efferocytosis, Circadian entrainment,
Synaptic vesicle cycle, Taste transduction, Epithelial cell signaling in
Helicobacter pylori infection, Pertussis, Staphylococcus aureus
infection (7 pathways)</li>
</ul>
</div>
</div>
<div id="wikipathway-enrichment" class="section level2">
<h2>4. WikiPathway Enrichment</h2>
<p>IAN runs enrichment analysis, filters the significant terms, prepares
metadata and generates the LLM based agent response, analyzing the data
like a human expert.</p>
<div id="wikipathway-enrichment-results" class="section level3">
<h3>4.1. WikiPathway Enrichment Results</h3>
<p>WikiPathway enrichment analysis results, filtered</p>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["ID"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Description"],"name":[2],"type":["chr"],"align":["left"]},{"label":["pvalue"],"name":[3],"type":["dbl"],"align":["right"]},{"label":["Gene"],"name":[4],"type":["chr"],"align":["left"]},{"label":["neglog10p"],"name":[5],"type":["dbl"],"align":["right"]}],"data":[{"1":"WP5473","2":"Cytokine cytokine receptor interaction","3":"7.580261e-06","4":"TNFSF12,IL27,RELT,IL17C,TNFRSF12A,CX3CR1,CXCL16,ACKR3,FASLG,CCR9,GDF15,CXCR1,CXCL5,XCR1,IL31RA,CCR8,CXCR2,TNFRSF17,CXCL1,CCL4L2,CCL4L1,CXCL17,CCL14","5":"5.120316"},{"1":"WP455","2":"GPCRs class A rhodopsin like","3":"3.263765e-05","4":"AVPR2,DRD4,GPR37L1,CX3CR1,AVPR1A,ACKR3,GALR2,ADORA2A,P2RY2,CCR9,GPER1,CXCR1,XCR1,CCR8,CXCR2,PTGER1,F2RL2,FPR3,ADRA2B,EDNRB,GPR15,HRH1","5":"4.486281"},{"1":"WP24","2":"Peptide GPCRs","3":"1.350392e-04","4":"AVPR2,CX3CR1,AVPR1A,GALR2,CCR9,CXCR1,CCR8,CXCR2,FPR3,EDNRB","5":"3.869540"},{"1":"WP5090","2":"Complement system in neuronal development and plasticity","3":"6.416529e-04","4":"GAS6,CRB2,C2,C1QB,CX3CR1,C1QA,CR2,VTN,C1QC,FASLG,CFB","5":"3.192700"},{"1":"WP545","2":"Complement activation","3":"7.031240e-04","4":"C2,C1QB,C1QA,C1QC,CFB","5":"3.152968"},{"1":"WP3937","2":"Microglia pathogen phagocytosis pathway","3":"1.627425e-03","4":"CYBA,TYROBP,C1QB,C1QA,C1QC,FCGR1A","5":"2.788499"},{"1":"WP5345","2":"1p36 copy number variation syndrome","3":"1.739934e-03","4":"C1QTNF12,SAMD11,AGRN,PLEKHN1,BTLA,TAS1R3,VTN,HES4,PERM1,RNF223","5":"2.759467"},{"1":"WP558","2":"Complement and coagulation cascades","3":"2.479402e-03","4":"C2,C1QB,C1QA,CR2,C1QC,SERPIND1,CFB","5":"2.605653"},{"1":"WP3896","2":"Dengue 2 interactions with complement and coagulation cascades","3":"2.737302e-03","4":"C2,C1QB,C1QA,CR2,C1QC,SERPIND1,CFB","5":"2.562677"},{"1":"WP516","2":"Hypertrophy model","3":"3.411972e-03","4":"EIF4EBP1,JUND,NR4A3,HBEGF","5":"2.466994"},{"1":"WP5373","2":"Osteoarthritic chondrocyte hypertrophy","3":"5.149902e-03","4":"FOSL1,JUND,RELB,CEBPB,COL1A1,ACAN","5":"2.288201"},{"1":"WP4539","2":"Synaptic signaling associated with autism spectrum disorder","3":"5.682357e-03","4":"EIF4EBP1,GRIN2D,GRIN1,GRIN2C,ARC,PRKAG3","5":"2.245471"},{"1":"WP2596","2":"Gastric acid production","3":"7.467842e-03","4":"MUC6,SCT,PGC","5":"2.126805"},{"1":"WP5095","2":"Overview of proinflammatory and profibrotic mediators","3":"8.736946e-03","4":"IL27,IL17C,CXCL16,CXCL5,AREG,CXCL1,CCL4L2,CCL4L1,CXCL17,CCL14","5":"2.058640"},{"1":"WP3941","2":"Oxidative damage response","3":"8.799327e-03","4":"C2,C1QB,C1QA,CR2,C1QC","5":"2.055551"},{"1":"WP4222","2":"Phosphodiesterases in neuronal function","3":"8.963260e-03","4":"GRIN2D,GRIN1,GRIN2C,GUCY1B1,ADORA2A,PDE3A","5":"2.047534"},{"1":"WP5380","2":"5q35 copy number variation","3":"9.517064e-03","4":"CDHR5,UNC5A,COX7A1,PRR7,MXD3,PRELID1,GRIN1,PDLIM7,NTN1","5":"2.021497"},{"1":"WP5398","2":"NRXN1 deletion syndrome","3":"1.614427e-02","4":"GRIN2D,GRIN1,GRIN2C","5":"1.791981"},{"1":"WP430","2":"Statin inhibition of cholesterol production","3":"1.679405e-02","4":"MIR33B,PDIA2,APOE,LPL","5":"1.774845"},{"1":"WP4008","2":"NO cGMP PKG mediated neuroprotection","3":"1.710131e-02","4":"GRIN2D,GRIN1,GRIN2C,GUCY1B1,PDE3A","5":"1.766971"},{"1":"WP4875","2":"Disruption of postsynaptic signaling by CNV","3":"2.077518e-02","4":"GRIN2D,GRIN1,GRIN2C,ARC","5":"1.682455"},{"1":"WP2267","2":"Synaptic vesicle pathway","3":"2.361576e-02","4":"DNM3,CPLX1,SYN1,CPLX2,SLC22A3","5":"1.626798"},{"1":"WP4874","2":"CAMKK2 pathway","3":"2.554949e-02","4":"C1QTNF12,TRPV4,PFKFB3,S100A8,FAM20C,CCR9,IRGC,AQP1","5":"1.592618"},{"1":"WP5474","2":"Catabolism of skeletal muscle in cachexia","3":"3.898711e-02","4":"TNFSF12,RELB,TNFRSF12A,CEBPB","5":"1.409079"},{"1":"WP3601","2":"Lipid particles composition","3":"3.932026e-02","4":"APOE,LPL","5":"1.405384"},{"1":"WP4148","2":"Splicing factor NOVA regulated synaptic proteins","3":"4.544619e-02","4":"GRIN1,AGRN,RAP1GAP,KCNMA1","5":"1.342503"},{"1":"WP80","2":"Nucleotide GPCRs","3":"4.705380e-02","4":"ADORA2A,P2RY2","5":"1.327405"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="wikipathway-enrichment-analysis-plot" class="section level3">
<h3>4.2. WikiPathway Enrichment Analysis Plot</h3>
<p>WikiPathway enrichment analysis results, filtered - plot</p>
<p><img src="report_template_files/figure-html/wp_filtered_plot%7D-1.png" width="768" /><a href='wp_enrichment_plot.png' download>Download
Plot as PNG</a></p>
</div>
<div id="wikipathway-llm-agent-response" class="section level3">
<h3>4.3. WikiPathway LLM Agent Response</h3>
<p>Agent 1: <strong>1. Summary and Categorization:</strong></p>
<p>The significantly enriched WikiPathways reveal a strong involvement
of immune response pathways, particularly those related to complement
activation and cytokine signaling, in Behcet’s disease (BD) patients
compared to healthy controls. Additionally, several pathways related to
neuronal function and synaptic signaling are enriched, suggesting
potential neuro-inflammatory components of the disease. Finally,
pathways related to lipid metabolism and bone development are also
implicated.</p>
<p><strong>Categorization:</strong></p>
<ul>
<li><strong>Immune Response:</strong> Complement and coagulation
cascades (WP558, WP3896, WP545, WP5090), Cytokine-cytokine receptor
interaction (WP5473), Microglia pathogen phagocytosis (WP3937), Overview
of proinflammatory and profibrotic mediators (WP5095). (4 pathways)</li>
<li><strong>Neuronal Function/Synaptic Signaling:</strong> Synaptic
vesicle pathway (WP2267), NO cGMP PKG mediated neuroprotection (WP4008),
Phosphodiesterases in neuronal function (WP4222), Splicing factor NOVA
regulated synaptic proteins (WP4148), Synaptic signaling associated with
autism spectrum disorder (WP4539), Disruption of postsynaptic signaling
by CNV (WP4875), Complement system in neuronal development and
plasticity (WP5090). (7 pathways)</li>
<li><strong>Lipid Metabolism:</strong> Lipid particles composition
(WP3601), Statin inhibition of cholesterol production (WP430). (2
pathways)</li>
<li><strong>Bone Development/Remodeling:</strong> Osteoarthritic
chondrocyte hypertrophy (WP5373), 5q35 copy number variation (WP5380),
Biomineral tissue development (GO). (3 pathways/GO)</li>
</ul>
</div>
</div>
<div id="reactome-enrichment" class="section level2">
<h2>5. Reactome Enrichment</h2>
<div id="reactome-pathways-enrichment-results" class="section level3">
<h3>5.1. Reactome Pathways Enrichment Results</h3>
<p>Reactome Pathways enrichment analysis results, filtered</p>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["ID"],"name":[1],"type":["chr"],"align":["left"]},{"label":["Description"],"name":[2],"type":["chr"],"align":["left"]},{"label":["pvalue"],"name":[3],"type":["dbl"],"align":["right"]},{"label":["Gene"],"name":[4],"type":["chr"],"align":["left"]},{"label":["neglog10p"],"name":[5],"type":["dbl"],"align":["right"]}],"data":[{"1":"R-HSA-500792","2":"GPCR ligand binding","3":"1.580820e-08","4":"PLPPR3,AVPR2,DRD4,GPR37L1,GNG13,CX3CR1,CXCL16,AVPR1A,TAS1R3,ACKR3,GALR2,ADORA2A,TAS2R4,TAS2R3,P2RY2,LHB,DHH,CCR9,SCT,GPER1,KISS1R,CXCR1,CXCL5,XCR1,CCR8,TAS2R5,CXCR2,PTGER1,F2RL2,CXCL1,ADM,FPR3,CCL4L1,ADRA2B,IHH,EDNRB,GCGR,HRH1","5":"7.801118"},{"1":"R-HSA-373076","2":"Class A/1 (Rhodopsin-like receptors)","3":"7.269476e-07","4":"PLPPR3,AVPR2,DRD4,GPR37L1,CX3CR1,CXCL16,AVPR1A,ACKR3,GALR2,ADORA2A,P2RY2,LHB,CCR9,GPER1,KISS1R,CXCR1,CXCL5,XCR1,CCR8,CXCR2,PTGER1,F2RL2,CXCL1,FPR3,CCL4L1,ADRA2B,EDNRB,HRH1","5":"6.138497"},{"1":"R-HSA-380108","2":"Chemokine receptors bind chemokines","3":"1.068933e-06","4":"CX3CR1,CXCL16,ACKR3,CCR9,CXCR1,CXCL5,XCR1,CCR8,CXCR2,CXCL1,CCL4L1","5":"5.971050"},{"1":"R-HSA-375276","2":"Peptide ligand-binding receptors","3":"2.235133e-06","4":"AVPR2,GPR37L1,CX3CR1,CXCL16,AVPR1A,ACKR3,GALR2,CCR9,GPER1,KISS1R,CXCR1,CXCL5,XCR1,CCR8,CXCR2,F2RL2,CXCL1,FPR3,CCL4L1,EDNRB","5":"5.650697"},{"1":"R-HSA-418594","2":"G alpha (i) signalling events","3":"7.675478e-05","4":"PRKACB,DRD4,GPR37L1,GNG13,CX3CR1,CXCL16,TAS1R3,ACKR3,GALR2,TAS2R4,TAS2R3,CCR9,GPER1,CXCR1,CXCL5,CCR8,TAS2R5,CXCR2,CXCL1,FPR3,CCL4L2,CCL4L1,ADRA2B","5":"4.114895"},{"1":"R-HSA-9031628","2":"NGF-stimulated transcription","3":"1.311708e-04","4":"FOSL1,JUND,NAB2,ARC,ID1,EGR3,VGF","5":"3.882163"},{"1":"R-HSA-977606","2":"Regulation of Complement cascade","3":"4.374302e-04","4":"C2,C1QB,C1QA,CR2,VTN,C1QC,CFB","5":"3.359091"},{"1":"R-HSA-166663","2":"Initial triggering of complement","3":"4.893353e-04","4":"C2,C1QB,C1QA,C1QC,CFB","5":"3.310393"},{"1":"R-HSA-166658","2":"Complement cascade","3":"1.581895e-03","4":"C2,C1QB,C1QA,CR2,VTN,C1QC,CFB","5":"2.800822"},{"1":"R-HSA-198725","2":"Nuclear Events (kinase and transcription factor activation)","3":"2.127548e-03","4":"FOSL1,JUND,NAB2,ARC,ID1,EGR3,VGF","5":"2.672121"},{"1":"R-HSA-187037","2":"Signaling by NTRK1 (TRKA)","3":"2.228594e-03","4":"FOSL1,JUND,MAPK12,NAB2,DNM3,ADORA2A,ARC,ID1,EGR3,VGF","5":"2.651969"},{"1":"R-HSA-381426","2":"Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","3":"4.088536e-03","4":"TMEM132A,GAS6,IGFALS,FAM20C,FAM20A,ENAM,SERPIND1,ALB,APOE,VGF","5":"2.388432"},{"1":"R-HSA-8957275","2":"Post-translational protein phosphorylation","3":"4.843707e-03","4":"TMEM132A,GAS6,FAM20C,FAM20A,ENAM,SERPIND1,ALB,APOE,VGF","5":"2.314822"},{"1":"R-HSA-166520","2":"Signaling by NTRKs","3":"6.655677e-03","4":"FOSL1,JUND,MAPK12,NAB2,DNM3,ADORA2A,ARC,ID1,EGR3,VGF","5":"2.176808"},{"1":"R-HSA-9717207","2":"Sensory perception of sweet, bitter, and umami (glutamate) taste","3":"7.040173e-03","4":"GNG13,TAS1R3,TAS2R4,TAS2R3,TAS2R5","5":"2.152417"},{"1":"R-HSA-166786","2":"Creation of C4 and C2 activators","3":"7.444368e-03","4":"C1QB,C1QA,C1QC","5":"2.128172"},{"1":"R-HSA-418555","2":"G alpha (s) signalling events","3":"7.563964e-03","4":"PRKACB,AVPR2,GNG13,ADORA2A,LHB,SCT,GPER1,PDE3A,ADM,GPR15,GCGR","5":"2.121251"},{"1":"R-HSA-2173782","2":"Binding and Uptake of Ligands by Scavenger Receptors","3":"7.801296e-03","4":"ALB,APOE,SSC5D,MARCO,COL1A1","5":"2.107833"},{"1":"R-HSA-3000170","2":"Syndecan interactions","3":"7.862291e-03","4":"VTN,ITGB4,SDC3,COL1A1","5":"2.104451"},{"1":"R-HSA-3000171","2":"Non-integrin membrane-ECM interactions","3":"7.934839e-03","4":"AGRN,VTN,COL4A4,ITGB4,SDC3,COL1A1","5":"2.100462"},{"1":"R-HSA-9717189","2":"Sensory perception of taste","3":"1.247451e-02","4":"GNG13,TAS1R3,TAS2R4,TAS2R3,TAS2R5","5":"1.903976"},{"1":"R-HSA-8941326","2":"RUNX2 regulates bone development","3":"1.434515e-02","4":"SMAD6,RBM14-RBM4,COL1A1,IHH","5":"1.843295"},{"1":"R-HSA-5083625","2":"Defective GALNT3 causes HFTC","3":"1.528585e-02","4":"MUC5B,MUC6,MUC5AC","5":"1.815710"},{"1":"R-HSA-5083636","2":"Defective GALNT12 causes CRCS1","3":"1.528585e-02","4":"MUC5B,MUC6,MUC5AC","5":"1.815710"},{"1":"R-HSA-5676594","2":"TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3":"1.528585e-02","4":"TNFSF12,TNFRSF12A,TNFSF12-TNFSF13","5":"1.815710"},{"1":"R-HSA-8963899","2":"Plasma lipoprotein remodeling","3":"1.766457e-02","4":"ANGPTL4,ALB,APOE,LPL","5":"1.752897"},{"1":"R-HSA-198933","2":"Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","3":"1.775898e-02","4":"HCST,TYROBP,NECTIN2,CD200R1,MADCAM1,SLAMF6,CLEC4G,FCGR1A,COL1A1","5":"1.750582"},{"1":"R-HSA-3000480","2":"Scavenging by Class A Receptors","3":"1.775945e-02","4":"APOE,MARCO,COL1A1","5":"1.750571"},{"1":"R-HSA-5083632","2":"Defective C1GALT1C1 causes TNPS","3":"1.775945e-02","4":"MUC5B,MUC6,MUC5AC","5":"1.750571"},{"1":"R-HSA-8849932","2":"Synaptic adhesion-like molecules","3":"2.333541e-02","4":"GRIN2D,GRIN1,GRIN2C","5":"1.631985"},{"1":"R-HSA-3000178","2":"ECM proteoglycans","3":"2.537902e-02","4":"AGRN,VTN,COL4A4,COMP,COL1A1,ACAN","5":"1.595525"},{"1":"R-HSA-438066","2":"Unblocking of NMDA receptors, glutamate binding and activation","3":"2.643849e-02","4":"GRIN2D,GRIN1,GRIN2C","5":"1.577763"},{"1":"R-HSA-9617324","2":"Negative regulation of NMDA receptor-mediated neuronal transmission","3":"2.643849e-02","4":"GRIN2D,GRIN1,GRIN2C","5":"1.577763"},{"1":"R-HSA-420499","2":"Class C/3 (Metabotropic glutamate/pheromone receptors)","3":"2.792308e-02","4":"TAS1R3,TAS2R4,TAS2R3,TAS2R5","5":"1.554037"},{"1":"R-HSA-416476","2":"G alpha (q) signalling events","3":"2.805538e-02","4":"GNG13,AVPR1A,P2RY2,KISS1R,DGKK,XCR1,HBEGF,PTGER1,F2RL2,EDNRB,GCGR,HRH1","5":"1.551984"},{"1":"R-HSA-9820960","2":"Respiratory syncytial virus (RSV) attachment and entry","3":"2.975105e-02","4":"AGRN,CX3CR1,SDC3","5":"1.526498"},{"1":"R-HSA-8853659","2":"RET signaling","3":"3.032204e-02","4":"PRKACB,PDLIM7,RAP1GAP,NRTN","5":"1.518242"},{"1":"R-HSA-438064","2":"Post NMDA receptor activation events","3":"3.164884e-02","4":"PRKACB,GRIN2D,GRIN1,GRIN2C,PRKAG3,TUBB3","5":"1.499642"},{"1":"R-HSA-9609736","2":"Assembly and cell surface presentation of NMDA receptors","3":"3.283900e-02","4":"GRIN2D,GRIN1,GRIN2C,TUBB3","5":"1.483610"},{"1":"R-HSA-9620244","2":"Long-term potentiation","3":"3.327189e-02","4":"GRIN2D,GRIN1,GRIN2C","5":"1.477922"},{"1":"R-HSA-2151209","2":"Activation of PPARGC1A (PGC-1alpha) by phosphorylation","3":"3.391780e-02","4":"MAPK12,PRKAG3","5":"1.469572"},{"1":"R-HSA-8963901","2":"Chylomicron remodeling","3":"3.391780e-02","4":"APOE,LPL","5":"1.469572"},{"1":"R-HSA-8964058","2":"HDL remodeling","3":"3.391780e-02","4":"ALB,APOE","5":"1.469572"},{"1":"R-HSA-977068","2":"Termination of O-glycan biosynthesis","3":"3.699933e-02","4":"MUC5B,MUC6,MUC5AC","5":"1.431806"},{"1":"R-HSA-432040","2":"Vasopressin regulates renal water homeostasis via Aquaporins","3":"3.822908e-02","4":"PRKACB,AVPR2,GNG13,AQP1","5":"1.417606"},{"1":"R-HSA-375165","2":"NCAM signaling for neurite out-growth","3":"3.904780e-02","4":"AGRN,COL4A4,SPTBN4,SPTA1,NRTN","5":"1.408403"},{"1":"R-HSA-9818030","2":"NFE2L2 regulating tumorigenic genes","3":"4.065388e-02","4":"MAFK,AREG","5":"1.390898"},{"1":"R-HSA-216083","2":"Integrin cell surface interactions","3":"4.080163e-02","4":"AGRN,MADCAM1,VTN,COL4A4,COMP,COL1A1","5":"1.389323"},{"1":"R-HSA-975634","2":"Retinoid metabolism and transport","3":"4.110283e-02","4":"AGRN,SDC3,APOE,LPL","5":"1.386128"},{"1":"R-HSA-913709","2":"O-linked glycosylation of mucins","3":"4.136757e-02","4":"MUC5B,MUC6,B3GNT4,MUC5AC,GALNT5","5":"1.383340"},{"1":"R-HSA-9707564","2":"Cytoprotection by HMOX1","3":"4.136757e-02","4":"NCOR2,SMARCD3,MAFK,SCO2,ALB","5":"1.383340"},{"1":"R-HSA-622323","2":"Presynaptic nicotinic acetylcholine receptors","3":"4.784421e-02","4":"CHRNG,CHRND","5":"1.320171"},{"1":"R-HSA-9634600","2":"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism","3":"4.784421e-02","4":"PRKACB,PFKFB3","5":"1.320171"},{"1":"R-HSA-5621480","2":"Dectin-2 family","3":"4.939712e-02","4":"MUC5B,MUC6,MUC5AC","5":"1.306298"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="reactome-pathways-enrichment-analysis-plot"
class="section level3">
<h3>5.2. Reactome Pathways Enrichment Analysis Plot</h3>
<p>Reactome Pathways enrichment analysis results, filtered - plot</p>
<p><img src="report_template_files/figure-html/reactome_filtered_plot%7D-1.png" width="672" /></p>
</div>
<div id="reactome-pathways-llm-agent-response" class="section level3">
<h3>5.3. Reactome Pathways LLM Agent Response</h3>
<p>Agent 3: <strong>1. Summary and Categorization:</strong></p>
<p>The significantly enriched Reactome pathways in this Behcet’s disease
transcriptomics study primarily highlight dysregulation in immune
response, particularly complement activation, and various G
protein-coupled receptor (GPCR) signaling pathways. These pathways are
interconnected, suggesting a complex interplay of immune and signaling
mechanisms contributing to the disease phenotype. Additionally, pathways
related to ECM interactions and lipoprotein remodeling are also
significantly enriched.</p>
<p><strong>Categorization of Enriched Pathways:</strong></p>
<ul>
<li><strong>Immune Response:</strong> Complement cascade (R-HSA-166658,
R-HSA-166663, R-HSA-977606), Regulation of Complement cascade
(R-HSA-977606), Immunoregulatory interactions between a Lymphoid and a
non-Lymphoid cell (R-HSA-198933), Dectin-2 family (R-HSA-5621480), TNF
receptor superfamily (TNFSF) members mediating non-canonical NF-kB
pathway (R-HSA-5676594) (5 pathways)</li>
<li><strong>GPCR Signaling:</strong> Class A/1 (Rhodopsin-like
receptors) (R-HSA-373076), Peptide ligand-binding receptors
(R-HSA-375276), Chemokine receptors bind chemokines (R-HSA-380108), G
alpha (q) signalling events (R-HSA-416476), G alpha (s) signalling
events (R-HSA-418555), G alpha (i) signalling events (R-HSA-418594),
Class C/3 (Metabotropic glutamate/pheromone receptors) (R-HSA-420499),
GPCR ligand binding (R-HSA-500792), Sensory perception of taste
(R-HSA-9717189), Sensory perception of sweet, bitter, and umami
(glutamate) taste (R-HSA-9717207) (10 pathways)</li>
<li><strong>ECM Interactions:</strong> Integrin cell surface
interactions (R-HSA-216083), Non-integrin membrane-ECM interactions
(R-HSA-3000171), ECM proteoglycans (R-HSA-3000178), Syndecan
interactions (R-HSA-3000170), Retinoid metabolism and transport
(R-HSA-975634) (5 pathways)</li>
<li><strong>Other Metabolic Processes:</strong> Regulation of
Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like
Growth Factor Binding Proteins (IGFBPs) (R-HSA-381426), Plasma
lipoprotein remodeling (R-HSA-8963899), Chylomicron remodeling
(R-HSA-8963901), HDL remodeling (R-HSA-8964058), O-linked glycosylation
of mucins (R-HSA-913709), Termination of O-glycan biosynthesis
(R-HSA-977606) (6 pathways)</li>
</ul>
</div>
</div>
<div id="gene-ontology-enrichment" class="section level2">
<h2>6. Gene Ontology Enrichment</h2>
<div id="gene-ontology-enrichment-results" class="section level3">
<h3>6.1. Gene Ontology Enrichment Results</h3>
<p>Gene Ontology enrichment analysis results, filtered</p>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["Description"],"name":[1],"type":["chr"],"align":["left"]},{"label":["pvalue"],"name":[2],"type":["dbl"],"align":["right"]},{"label":["Gene"],"name":[3],"type":["chr"],"align":["left"]},{"label":["neglog10p"],"name":[4],"type":["dbl"],"align":["right"]}],"data":[{"1":"positive regulation of cytosolic calcium ion concentration","2":"3.667475e-06","3":"LPAR2, GRIN1, TRPV4, CX3CR1, AVPR1A, ACKR3, GALR2, P2RX2, CCR9, GPER1, CXCR1, XCR1, CD24, CCR8, CXCR2, PTGER1, ADM, FPR3, EDNRB","4":"5.435633"},{"1":"chemokine-mediated signaling pathway","2":"5.854415e-05","3":"CX3CR1, ACKR3, CCR9, CXCR1, CXCL5, XCR1, CCR8, CXCR2, FOXC1, CXCL1, CCL4L1, CCL14","4":"4.232516"},{"1":"cellular response to chemokine","2":"1.316365e-04","3":"CX3CR1, ACKR3, CCR9, CXCR1, CXCL5, XCR1, CCR8, CXCR2, FOXC1, CXCL1, CCL4L1, CCL14","4":"3.880624"},{"1":"response to chemokine","2":"1.316365e-04","3":"CX3CR1, ACKR3, CCR9, CXCR1, CXCL5, XCR1, CCR8, CXCR2, FOXC1, CXCL1, CCL4L1, CCL14","4":"3.880624"},{"1":"response to dietary excess","2":"1.564768e-04","3":"TRPV4, PCSK1N, WNK4, SCT, GDF15, APOE, VGF","4":"3.805550"},{"1":"energy homeostasis","2":"2.805813e-04","3":"TRPV4, METRNL, PCSK1N, MLXIPL, WNK4, SCT, GDF15, APOE, NR4A3, VGF","4":"3.551941"},{"1":"chemotaxis","2":"4.609028e-04","3":"GAS6, FOSL1, TRPV4, CX3CR1, CXCL16, S100A8, ACKR3, TYMP, CCR9, S100A12, NTN1, CXCR1, SERPIND1, CXCL5, SEMA6B, XCR1, HBEGF, CHGA, CCR8, CXCR2, EGR3, LRTM2, CXCL1, SEMA3F, FPR3, CCL4L1, CXCL17, DEFA1B, EDNRB, CCL14","4":"3.336391"},{"1":"myeloid leukocyte activation","2":"4.673884e-04","3":"SBNO2, TYROBP, SPHK1, SPI1, RELB, NECTIN2, CX3CR1, C1QA, HAMP, DYSF, WNK4, S100A12, TLR3, NR4A3, CPLX2, IL31RA, CHGA, BATF2, CXCR2","4":"3.330322"},{"1":"excitatory chemical synaptic transmission","2":"4.841319e-04","3":"GRIN2D, GRIN1, GRIN2C, PDLIM4","4":"3.315036"},{"1":"taxis","2":"4.945518e-04","3":"GAS6, FOSL1, TRPV4, CX3CR1, CXCL16, S100A8, ACKR3, TYMP, CCR9, S100A12, NTN1, CXCR1, SERPIND1, CXCL5, SEMA6B, XCR1, HBEGF, CHGA, CCR8, CXCR2, EGR3, LRTM2, CXCL1, SEMA3F, FPR3, CCL4L1, CXCL17, DEFA1B, EDNRB, CCL14","4":"3.305788"},{"1":"endochondral bone morphogenesis","2":"7.955003e-04","3":"SCX, TRPV4, NAB2, TMEM119, COMP, FOXC1, COL1A1, IHH","4":"3.099360"},{"1":"endosomal lumen acidification","2":"9.284223e-04","3":"ATP6V1F, ATP6V0C, RNASEK, FASLG","4":"3.032254"},{"1":"positive regulation of phospholipid transport","2":"9.284223e-04","3":"PRELID1, ATP8A2, FASLG, APOE","4":"3.032254"},{"1":"synapse pruning","2":"9.284223e-04","3":"C1QB, CX3CR1, C1QA, C1QC","4":"3.032254"},{"1":"vascular process in circulatory system","2":"9.284967e-04","3":"AVPR2, TRPV4, SLC7A5, AVPR1A, ADORA2A, P2RY2, GPER1, COMP, APOE, PDE3A, CXCR2, SLC7A3, SLC1A2, FOXC1, ADM, SLC22A3, ADRA2B, EDNRB, KCNMA1, HRH1","4":"3.032220"},{"1":"cell chemotaxis","2":"1.199562e-03","3":"GAS6, TRPV4, CX3CR1, CXCL16, S100A8, ACKR3, CCR9, S100A12, CXCR1, CXCL5, XCR1, HBEGF, CHGA, CCR8, CXCR2, EGR3, CXCL1, CCL4L1, CXCL17, DEFA1B, EDNRB, CCL14","4":"2.920977"},{"1":"regulation of phospholipid transport","2":"1.232937e-03","3":"PRELID1, ATP8A2, FASLG, APOE","4":"2.909059"},{"1":"regulation of vascular permeability","2":"1.252679e-03","3":"TRPV4, ADORA2A, APOE, PDE3A, CXCR2, ADM, HRH1","4":"2.902160"},{"1":"animal organ regeneration","2":"1.500584e-03","3":"GAS6, SLC7A5, VTN, CEBPB, NR4A3, ADM, IHH, NNMT","4":"2.823740"},{"1":"retina morphogenesis in camera-type eye","2":"1.500584e-03","3":"SAMD11, ROM1, CRB2, CABP4, ATP8A2, RS1, TFAP2A, IHH","4":"2.823740"},{"1":"neural retina development","2":"1.582761e-03","3":"SAMD11, SMARCD3, ROM1, CRB2, CABP4, ATP8A2, RS1, TFAP2A, IHH","4":"2.800585"},{"1":"bone morphogenesis","2":"1.678896e-03","3":"IFITM5, SCX, TRPV4, NAB2, TMEM119, COMP, FOXC1, COL1A1, TFAP2A, IHH","4":"2.774976"},{"1":"blood vessel diameter maintenance","2":"1.718231e-03","3":"AVPR2, AVPR1A, ADORA2A, P2RY2, GPER1, COMP, APOE, FOXC1, ADM, ADRA2B, EDNRB, KCNMA1, HRH1","4":"2.764919"},{"1":"regulation of tube diameter","2":"1.718231e-03","3":"AVPR2, AVPR1A, ADORA2A, P2RY2, GPER1, COMP, APOE, FOXC1, ADM, ADRA2B, EDNRB, KCNMA1, HRH1","4":"2.764919"},{"1":"regulation of tube size","2":"1.822264e-03","3":"AVPR2, AVPR1A, ADORA2A, P2RY2, GPER1, COMP, APOE, FOXC1, ADM, ADRA2B, EDNRB, KCNMA1, HRH1","4":"2.739389"},{"1":"preganglionic parasympathetic fiber development","2":"2.039012e-03","3":"PHOX2A, ACKR3, SEMA3F, TFAP2A","4":"2.690580"},{"1":"response to muscle activity","2":"2.082711e-03","3":"TNS2, SLC7A5, METRNL, PERM1, PRKAG3","4":"2.681371"},{"1":"phospholipase C-activating G protein-coupled receptor signaling pathway","2":"2.101215e-03","3":"GNG13, CX3CR1, GALR2, P2RY2, CHGA, CXCR2, TGM2, FPR3, EDNRB, HRH1","4":"2.677529"},{"1":"immunoglobulin production","2":"2.157933e-03","3":"KMT5C, TRAV14DV4, IGKV2D-30, FCRL3, IGLV4-69, IGLV4-60, IGKV2-30, IGKV1D-13, IGLV3-12, IGKV1-13, IGKV3D-15, IGLV5-45, IGKV3D-11, IGKV2-29, IGLV1-50","4":"2.665962"},{"1":"regulation of biomineral tissue development","2":"2.259607e-03","3":"GAS6, IFITM5, FAM20C, CEBPB, TMEM119, COMP, ENAM, RFLNA, ZNF664-RFLNA, TFAP2A","4":"2.645967"},{"1":"defense response to fungus","2":"2.450657e-03","3":"SPI1, CX3CR1, S100A8, HAMP, S100A12, CHGA, DEFA1B","4":"2.610718"},{"1":"positive regulation of vascular permeability","2":"2.553302e-03","3":"TRPV4, APOE, PDE3A, CXCR2","4":"2.592898"},{"1":"positive regulation of MAPK cascade","2":"2.591181e-03","3":"MAPK8IP3, GAS6, DRD4, LPAR2, SPHK1, SPI1, TRPV4, MAPK8IP2, GPR37L1, FCRL3, MAPK8IP1, ACKR3, CAVIN3, AVPI1, S100A12, GPER1, TLR3, GDF15, MIR126, APOE, CD24, MARCO, TPD52L1, ARHGAP8, CCL4L1, ADRA2B, CXCL17, CCL14","4":"2.586502"},{"1":"biomineral tissue development","2":"2.831355e-03","3":"SBNO2, GAS6, IFITM5, FAM20C, CEBPB, TMEM119, COMP, FAM20A, ENAM, RFLNA, ZNF664-RFLNA, COL1A1, TFAP2A, CLEC3B","4":"2.548006"},{"1":"response to purine-containing compound","2":"2.980701e-03","3":"FOSL1, PDXP, PER1, ADORA2A, P2RX2, P2RY2, PDE3A, AREG, COL1A1, VGF, AQP1, SLC26A3","4":"2.525682"},{"1":"regulation of neuronal synaptic plasticity","2":"3.001267e-03","3":"GRIN2D, GRIN1, GRIN2C, ACP4, ARC, APOE, VGF","4":"2.522695"},{"1":"macrophage activation involved in immune response","2":"3.150041e-03","3":"SBNO2, TYROBP, CX3CR1, DYSF","4":"2.501684"},{"1":"parasympathetic nervous system development","2":"3.150041e-03","3":"PHOX2A, ACKR3, SEMA3F, TFAP2A","4":"2.501684"},{"1":"renal system process","2":"3.434234e-03","3":"PRKACB, AVPR2, GAS6, MCAM, ADORA2A, WNK4, SLC22A12, ADM, AQP1, EDNRB, KCNMA1","4":"2.464170"},{"1":"response to organophosphorus","2":"3.647570e-03","3":"FOSL1, PDXP, PER1, P2RX2, P2RY2, PDE3A, AREG, COL1A1, VGF, AQP1, SLC26A3","4":"2.437996"},{"1":"macrophage activation","2":"3.656093e-03","3":"SBNO2, TYROBP, SPHK1, CX3CR1, C1QA, HAMP, DYSF, WNK4, TLR3, IL31RA","4":"2.436983"},{"1":"production of molecular mediator of immune response","2":"3.786056e-03","3":"KMT5C, TRAV14DV4, SLC7A5, IGKV2D-30, FCRL3, IGLV4-69, IGLV4-60, TLR3, IGKV2-30, NR4A3, IGKV1D-13, PGC, IGLV3-12, IGKV1-13, PRG2, IGKV3D-15, IGLV5-45, IGKV3D-11, IGKV2-29, IGLV1-50","4":"2.421813"},{"1":"mononuclear cell migration","2":"3.820089e-03","3":"GAS6, TRPV4, CD200R1, MADCAM1, CX3CR1, CXCL16, GCSAM, S100A12, CXCR1, CXCR2, CCL4L1, CXCL17, DEFA1B, GPR15, CCL14","4":"2.417927"},{"1":"camera-type eye photoreceptor cell differentiation","2":"3.825847e-03","3":"SAMD11, ROM1, CRB2, CABP4, IHH","4":"2.417272"},{"1":"endochondral ossification","2":"3.825847e-03","3":"SCX, NAB2, TMEM119, FOXC1, COL1A1","4":"2.417272"},{"1":"replacement ossification","2":"3.825847e-03","3":"SCX, NAB2, TMEM119, FOXC1, COL1A1","4":"2.417272"},{"1":"tooth mineralization","2":"3.825847e-03","3":"FAM20C, FAM20A, ENAM, COL1A1, TFAP2A","4":"2.417272"},{"1":"immunoglobulin mediated immune response","2":"4.178913e-03","3":"KMT5C, NECTIN2, BCL3, C2, C1QB, C1QA, CR2, C1QC, IGHV4-34, FCGR1A, IGHV3-7, IGHV2-26, IGHV3-74, IGHV1-69, IGHV3-72","4":"2.378937"},{"1":"regulation of endothelial cell apoptotic process","2":"4.381273e-03","3":"PAK4, GAS6, FASLG, GPER1, TNFAIP3, ANGPTL4, MIR126","4":"2.358400"},{"1":"cGMP-mediated signaling","2":"4.387830e-03","3":"GUCY1B1, APOE, PDE3A, AQP1, EDNRB","4":"2.357750"},{"1":"positive regulation of muscle contraction","2":"4.443805e-03","3":"SPHK1, TRPV4, ATP2A1, GPER1, CHGA, ADRA2B","4":"2.352245"},{"1":"regulation of urine volume","2":"4.614686e-03","3":"AVPR2, ADORA2A, ADM, EDNRB","4":"2.335858"},{"1":"calcium-mediated signaling","2":"4.859311e-03","3":"GRIN2D, GRIN1, SPHK1, GRIN2C, HOMER3, CX3CR1, AVPR1A, ACKR3, P2RX2, CCR9, CXCR1, XCR1, NEUROD2, CCR8, CXCR2, EDNRB","4":"2.313425"},{"1":"apoptotic cell clearance","2":"4.938950e-03","3":"GAS6, ADGRB1, TYROBP, C2, TGM2, MARCO","4":"2.306365"},{"1":"B cell mediated immunity","2":"4.979110e-03","3":"KMT5C, NECTIN2, BCL3, C2, C1QB, C1QA, CR2, C1QC, IGHV4-34, FCGR1A, IGHV3-7, IGHV2-26, IGHV3-74, IGHV1-69, IGHV3-72","4":"2.302848"},{"1":"chemical synaptic transmission, postsynaptic","2":"5.018008e-03","3":"ZACN, DRD4, GRIN2D, GRIN1, MAPK8IP2, GRIN2C, ADORA2A, P2RX2, CHRNG, CHRND","4":"2.299469"},{"1":"bone development","2":"5.657342e-03","3":"IFITM5, TYROBP, SCX, TRPV4, NAB2, FAM20C, TMEM119, COMP, RFLNA, ZNF664-RFLNA, TGM2, FOXC1, COL1A1, TFAP2A, IHH","4":"2.247388"},{"1":"regulation of synaptic plasticity","2":"5.899315e-03","3":"ADGRB1, TYROBP, GRIN2D, GRIN1, GRIN2C, ACP4, CX3CR1, ADORA2A, ARC, SCT, APOE, CPLX2, NEUROD2, VGF, HRH1","4":"2.229198"},{"1":"leukocyte chemotaxis","2":"5.944395e-03","3":"GAS6, TRPV4, CX3CR1, CXCL16, S100A8, S100A12, CXCR1, CXCL5, CHGA, CXCR2, CXCL1, CCL4L1, CXCL17, DEFA1B, EDNRB, CCL14","4":"2.225892"},{"1":"eye photoreceptor cell differentiation","2":"6.048978e-03","3":"SAMD11, ROM1, CRB2, CABP4, FSCN2, IHH","4":"2.218318"},{"1":"negative regulation of endothelial cell apoptotic process","2":"6.423672e-03","3":"PAK4, GAS6, TNFAIP3, ANGPTL4, MIR126","4":"2.192217"},{"1":"neuronal ion channel clustering","2":"6.429257e-03","3":"AGRN, SPTBN4, NRCAM","4":"2.191839"},{"1":"pancreatic juice secretion","2":"6.429257e-03","3":"WNK4, SCT, AQP1","4":"2.191839"},{"1":"regulation of synaptic vesicle fusion to presynaptic active zone membrane","2":"6.429257e-03","3":"CPLX1, CPLX2, DOC2A","4":"2.191839"},{"1":"regulation of synaptic vesicle membrane organization","2":"6.429257e-03","3":"CPLX1, CPLX2, DOC2A","4":"2.191839"},{"1":"regulation of body fluid levels","2":"6.438666e-03","3":"NCOR2, PRKACB, CYBA, AVPR2, GAS6, TRPV4, PDIA2, VTN, ADORA2A, WNK4, P2RY2, SCT, COMP, DGKK, SERPIND1, APOE, HGFAC, F2RL2, ADM, AQP1, ADRA2B, EDNRB","4":"2.191204"},{"1":"regulation of vesicle fusion","2":"6.478413e-03","3":"SPHK1, CPLX1, CPLX2, DOC2A","4":"2.188531"},{"1":"response to fungus","2":"6.723337e-03","3":"SPI1, CX3CR1, S100A8, HAMP, S100A12, CHGA, DEFA1B","4":"2.172415"},{"1":"regulation of digestive system process","2":"7.228461e-03","3":"HAMP, TYMP, WNK4, SCT, AQP1","4":"2.140954"},{"1":"endothelial cell apoptotic process","2":"7.285711e-03","3":"PAK4, GAS6, FASLG, GPER1, TNFAIP3, ANGPTL4, MIR126","4":"2.137528"},{"1":"cellular defense response","2":"7.330338e-03","3":"FOSL1, TYROBP, CX3CR1, ADORA2A, CCR9, CXCR2","4":"2.134876"},{"1":"regulation of angiogenesis","2":"7.614772e-03","3":"PAK4, JMJD8, EPN1, TNFSF12, ADGRB1, SPHK1, PLXND1, CX3CR1, MIR185, FASLG, MIR212, TLR3, TNFAIP3, ANGPTL4, MIR126, CXCR2, FOXC1, MIR640, ADM, AQP1, HSPB6","4":"2.118343"},{"1":"heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules","2":"8.039613e-03","3":"SCARF2, CRB2, NECTIN4, HMCN1, CEACAM6, CEACAM8","4":"2.094765"},{"1":"Golgi lumen acidification","2":"8.153740e-03","3":"ATP6V1F, ATP6V0C, RNASEK","4":"2.088643"},{"1":"regulation of protein depolymerization","2":"8.337203e-03","3":"APC2, MAP1S, PDXP, TRPV4, MAP6D1, LIMA1, SPTBN4, SPTA1","4":"2.078980"},{"1":"excitatory postsynaptic potential","2":"9.355927e-03","3":"ZACN, GRIN2D, GRIN1, MAPK8IP2, GRIN2C, ADORA2A, P2RX2, CHRNG, CHRND","4":"2.028913"},{"1":"adenylate cyclase-modulating G protein-coupled receptor signaling pathway","2":"9.359426e-03","3":"PRKACB, AVPR2, DRD4, ADGRB1, LPAR2, GPR37L1, GALR2, ADORA2A, GPER1, APLP1, CHGA, MARCO, PTGER1, ADM, ADRA2B, GCGR","4":"2.028751"},{"1":"anatomical structure maturation","2":"9.458876e-03","3":"ZBTB7A, REC8, AGRN, CX3CR1, C1QA, FAM20C, CEND1, SOX18, SPTBN4, RFLNA, ZNF664-RFLNA, CATSPERD, SLC26A3, IHH, EDNRB, DAZL, NRCAM","4":"2.024160"},{"1":"negative regulation of neuron projection development","2":"9.644176e-03","3":"TRPV4, ACP4, DNM3, RTN4RL2, NTN1, KREMEN1, APOE, SEMA6B, NEU4, SEMA3F, PTPRG","4":"2.015735"},{"1":"regulation of blood pressure","2":"9.880175e-03","3":"AVPR2, GAS6, CTSZ, GPR37L1, AVPR1A, P2RX2, WNK4, CHGA, ERAP2, ADM, ADRA2B, EDNRB, GCGR","4":"2.005235"},{"1":"regulation of vasculature development","2":"9.969385e-03","3":"PAK4, JMJD8, EPN1, TNFSF12, ADGRB1, SPHK1, PLXND1, CX3CR1, MIR185, FASLG, MIR212, TLR3, TNFAIP3, ANGPTL4, MIR126, CXCR2, FOXC1, MIR640, ADM, AQP1, HSPB6","4":"2.001332"},{"1":"adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains","2":"1.000531e-02","3":"KMT5C, IL27, RELB, NECTIN2, SOCS3, BCL3, C2, C1QB, C1QA, CR2, IL4I1, SLAMF6, C1QC, TNFAIP3, CLEC4G, IGHV4-34, FCGR1A, IGHV3-7, IGHV2-26, IGHV3-74, IGHV1-69, IGHV3-72","4":"1.999769"},{"1":"amelogenesis","2":"1.011188e-02","3":"RELT, FAM20C, FAM20A, ENAM","4":"1.995168"},{"1":"negative regulation of long-term synaptic potentiation","2":"1.012428e-02","3":"TYROBP, CX3CR1, APOE","4":"1.994636"},{"1":"positive regulation of striated muscle contraction","2":"1.012428e-02","3":"TRPV4, ATP2A1, CHGA","4":"1.994636"},{"1":"vitamin catabolic process","2":"1.012428e-02","3":"PDXP, CYP2W1, MTHFS","4":"1.994636"},{"1":"granulocyte chemotaxis","2":"1.044137e-02","3":"TRPV4, S100A8, S100A12, CXCR1, CXCL5, CXCR2, CXCL1, CCL4L1, CXCL17, CCL14","4":"1.981242"},{"1":"humoral immune response mediated by circulating immunoglobulin","2":"1.046231e-02","3":"BCL3, C2, C1QB, C1QA, CR2, C1QC","4":"1.980372"},{"1":"glial cell activation","2":"1.137373e-02","3":"TYROBP, SPHK1, CX3CR1, C1QA, ADORA2A, TLR3","4":"1.944097"},{"1":"intracellular pH reduction","2":"1.137373e-02","3":"ATP6V1F, ATP6V0C, RNASEK, RAB20, AVPR1A, FASLG","4":"1.944097"},{"1":"catecholamine transport","2":"1.141646e-02","3":"DRD4, ADORA2A, CHGA, SYT5, TGM2, SLC22A3, ADRA2B","4":"1.942469"},{"1":"cell junction disassembly","2":"1.156468e-02","3":"C1QB, CX3CR1, C1QA, C1QC","4":"1.936866"},{"1":"response to molecule of bacterial origin","2":"1.217990e-02","3":"SBNO2, TLR10, SLC7A5, C2, CX3CR1, S100A8, CEBPB, FASLG, TNFAIP3, SMAD6, CXCL5, CD180, CD24, SSC5D, CD68, PTGER1, PALM3, CXCL1, ADM, DEFA1B, EDNRB","4":"1.914356"},{"1":"behavioral fear response","2":"1.232100e-02","3":"DRD4, MAPK8IP2, APOE, NEUROD2, ASIC4","4":"1.909354"},{"1":"complement activation, classical pathway","2":"1.232100e-02","3":"C2, C1QB, C1QA, CR2, C1QC","4":"1.909354"},{"1":"negative regulation of androgen receptor signaling pathway","2":"1.234712e-02","3":"NCOR2, ZBTB7A, FOXH1","4":"1.908434"},{"1":"negative regulation of digestive system process","2":"1.234712e-02","3":"HAMP, WNK4, SCT","4":"1.908434"},{"1":"receptor-mediated endocytosis","2":"1.326285e-02","3":"RNASEK, DRD4, DNM3, MIR185, CXCL16, ACKR3, VTN, PDLIM7, ARC, CXCR1, FCGR1A, APOE, CXCR2, MARCO, HMMR, ADM","4":"1.877363"},{"1":"odontogenesis","2":"1.342562e-02","3":"RELT, ACP4, FAM20C, FAM20A, ENAM, FOXC1, ADM, COL1A1, TFAP2A, AQP1","4":"1.872066"},{"1":"behavioral defense response","2":"1.357095e-02","3":"DRD4, MAPK8IP2, APOE, NEUROD2, ASIC4","4":"1.867390"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="gene-ontology-enrichment-analysis-plot" class="section level3">
<h3>6.2. Gene Ontology Enrichment Analysis Plot</h3>
<p>Gene Ontology enrichment analysis results, filtered - plot - Top 20
Terms</p>
<p><img src="report_template_files/figure-html/go_filtered_plot%7D-1.png" width="672" /></p>
</div>
<div id="go-llm-agent-response" class="section level3">
<h3>6.3. GO LLM Agent Response</h3>
<p>Agent 5: <strong>1. Summary and Categorization:</strong></p>
<p>The significantly enriched GO terms primarily highlight immune
dysregulation, particularly within the adaptive and innate immune
systems, and processes related to vascular function and bone development
in Behcet’s disease (BD) patients compared to healthy controls. Several
GO terms relate to cell chemotaxis and signaling pathways influencing
vascular tone and permeability. The enrichment of bone development terms
is intriguing and warrants further investigation.</p>
<p><strong>Categorization of Enriched GO Terms:</strong></p>
<ul>
<li><strong>Immune Response:</strong> 27 terms (B cell mediated
immunity, adaptive immune response, humoral immune response,
immunoglobulin mediated immune response, immunoglobulin production,
complement activation, cellular defense response, cellular response to
chemokine, chemokine-mediated signaling pathway, chemotaxis, defense
response to fungus, macrophage activation, macrophage activation
involved in immune response, myeloid leukocyte activation, production of
molecular mediator of immune response, response to molecule of bacterial
origin, response to fungus)</li>
<li><strong>Vascular Function:</strong> 7 terms (blood vessel diameter
maintenance, regulation of blood pressure, positive regulation of
vascular permeability, regulation of vascular permeability, regulation
of vasculature development, vascular process in circulatory system,
regulation of body fluid levels)</li>
<li><strong>Bone Development:</strong> 5 terms (bone development, bone
morphogenesis, biomineral tissue development, endochondral bone
morphogenesis, endochondral ossification)</li>
<li><strong>Cell Signaling:</strong> 6 terms (adenylate
cyclase-modulating G protein-coupled receptor signaling pathway,
cGMP-mediated signaling, calcium-mediated signaling, phospholipase
C-activating G protein-coupled receptor signaling pathway, positive
regulation of MAPK cascade, excitatory chemical synaptic
transmission)</li>
</ul>
</div>
</div>
<div id="transcription-factor-enrichment" class="section level2">
<h2>7. Transcription Factor Enrichment</h2>
<div id="transcription-factor-chea-enrichment-results"
class="section level3">
<h3>7.1. Transcription Factor (ChEA) enrichment results</h3>
<p>Transcription Factor (ChEA) enrichment analysis results, filtered</p>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["Term"],"name":[1],"type":["chr"],"align":["left"]},{"label":["P.value"],"name":[2],"type":["dbl"],"align":["right"]},{"label":["Genes"],"name":[3],"type":["chr"],"align":["left"]},{"label":["neglog10p"],"name":[4],"type":["dbl"],"align":["right"]}],"data":[{"1":"RELB 30642670 ChIP-Seq CTB1 Human Placenta Inflammation","2":"0.04062133","3":"CCDC71L;PPP1R15A;ANKRD37;SPHK1;ROM1;TNFAIP3;CXCL1;AP5B1;LTC4S;KAZALD1;CXCL5;SOCS3;DDIT4;CDC42EP2;HBEGF","4":"1.391246"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="transcription-factor-chea-enrichment-analysis-plot"
class="section level3">
<h3>7.2. Transcription Factor (ChEA) Enrichment Analysis Plot</h3>
<p>Transcription Factor (ChEA) enrichment analysis results, filtered -
plot</p>
<p><img src="report_template_files/figure-html/chea_filtered_plot%7D-1.png" width="672" /></p>
</div>
<div id="chea-llm-agent-response" class="section level3">
<h3>7.3. ChEA LLM Agent Response</h3>
<p>Agent 4: <strong>1. Summary of Enriched Transcription
Factors:</strong></p>
<p>The ChEA analysis identified RELB as the only significantly enriched
transcription factor (p-value &lt; 0.05) among the differentially
expressed genes (DEGs) in Behcet’s disease (BD) patients compared to
healthy controls (HC). This suggests a potential role for RELB, a member
of the NF-κB family, in regulating the observed gene expression changes
in BD. The relatively small number of significantly enriched TFs might
reflect the complexity of BD pathogenesis, involving multiple
interacting regulatory mechanisms beyond single TF activity. The
analysis was performed on DEGs identified using DESeq from RNA-Seq data
of PBMCs from 9 BD patients and 10 HC.</p>
<p><strong>2. Regulatory Network Analysis:</strong></p>
<p>RELB, a key regulator of inflammation and immune responses, stands
out as a potential master regulator. Its target genes (CCDC71L,
PPP1R15A, ANKRD37, SPHK1, ROM1, TNFAIP3, CXCL1, AP5B1, LTC4S, KAZALD1,
CXCL5, SOCS3, DDIT4, CDC42EP2, HBEGF) are implicated in several enriched
pathways. These pathways include Cytokine-cytokine receptor interaction,
Viral protein interaction with cytokine and cytokine receptor, Chemokine
signaling pathway, Efferocytosis, Osteoclast differentiation, IL-17
signaling pathway, and Complement and coagulation cascades (KEGG and
WikiPathways). Many of RELB’s target genes are chemokines (CXCL1, CXCL5)
or receptors (CX3CR1, ACKR3, CCR9, CXCR1, CXCR2, XCR1, CCR8) involved in
immune cell recruitment and activation. The involvement of pathways like
complement and coagulation cascades suggests a potential link to the
inflammatory and thrombotic complications often observed in BD.</p>
</div>
</div>
<div id="protein-protein-interaction" class="section level2">
<h2>8. Protein-Protein Interaction</h2>
<div id="protein-protein-interaction-network-analysis"
class="section level3">
<h3>8.1. Protein-Protein Interaction Network Analysis</h3>
<p>The genes with high interactions scores are scored for network
properties and a combined score is calculated to identify important
genes. Top 10 genes are shown below.</p>
<pre><code>## ## Important Genes based on Network Properties</code></pre>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":[""],"name":["_rn_"],"type":[""],"align":["left"]},{"label":["node"],"name":[1],"type":["chr"],"align":["left"]},{"label":["combined_score_prop"],"name":[2],"type":["dbl"],"align":["right"]},{"label":["degree"],"name":[3],"type":["dbl"],"align":["right"]},{"label":["betweenness"],"name":[4],"type":["dbl"],"align":["right"]},{"label":["closeness"],"name":[5],"type":["dbl"],"align":["right"]},{"label":["eigenvector_centrality"],"name":[6],"type":["dbl"],"align":["right"]},{"label":["degree_scaled"],"name":[7],"type":["dbl[,1]"],"align":["right"]},{"label":["betweenness_scaled"],"name":[8],"type":["dbl[,1]"],"align":["right"]},{"label":["closeness_scaled"],"name":[9],"type":["dbl[,1]"],"align":["right"]},{"label":["eigenvector_scaled"],"name":[10],"type":["dbl[,1]"],"align":["right"]}],"data":[{"1":"ALB","2":"7.929247","3":"53","4":"31913.313","5":"0.0009652510","6":"1.0000000","7":"9.068485","8":"16.550979","9":"-0.2763051","10":"6.373829","_rn_":"1","_row":"ALB"},{"1":"PRKACB","2":"3.677661","3":"34","4":"15148.393","5":"0.0008517888","6":"0.3313142","7":"5.522097","8":"7.678932","9":"-0.2767997","10":"1.786416","_rn_":"2","_row":"PRKACB"},{"1":"CD68","2":"3.543149","3":"33","4":"6217.382","5":"0.0008264463","6":"0.9690420","7":"5.335445","8":"2.952614","9":"-0.2769101","10":"6.161446","_rn_":"3","_row":"CD68"},{"1":"CXCL1","2":"3.190171","3":"33","4":"3663.413","5":"0.0008038585","6":"0.9602606","7":"5.335445","8":"1.601046","9":"-0.2770086","10":"6.101203","_rn_":"4","_row":"CXCL1"},{"1":"APOE","2":"3.123509","3":"30","4":"6597.072","5":"0.0008417508","6":"0.7766895","7":"4.775489","8":"3.153547","9":"-0.2768434","10":"4.841842","_rn_":"5","_row":"APOE"},{"1":"CX3CR1","2":"2.887221","3":"29","4":"2871.274","5":"0.0007886435","6":"0.9535661","7":"4.588837","8":"1.181844","9":"-0.2770749","10":"6.055277","_rn_":"6","_row":"CX3CR1"},{"1":"PXDNL","2":"2.497756","3":"24","4":"6022.912","5":"0.0008583691","6":"0.6193615","7":"3.655577","8":"2.849700","9":"-0.2767710","10":"3.762518","_rn_":"7","_row":"PXDNL"},{"1":"FCGR1A","2":"2.120119","3":"22","4":"2987.091","5":"0.0007662835","6":"0.6878309","7":"3.282273","8":"1.243134","9":"-0.2771723","10":"4.232242","_rn_":"8","_row":"FCGR1A"},{"1":"CEBPB","2":"1.900429","3":"21","4":"5498.638","5":"0.0008237232","6":"0.3931698","7":"3.095621","8":"2.572253","9":"-0.2769220","10":"2.210766","_rn_":"9","_row":"CEBPB"},{"1":"COL1A1","2":"1.688010","3":"20","4":"4310.912","5":"0.0007818608","6":"0.3881705","7":"2.908969","8":"1.943704","9":"-0.2771044","10":"2.176469","_rn_":"10","_row":"COL1A1"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="protein-protein-interaction-network-analysis-plot"
class="section level3">
<h3>8.2. Protein-Protein Interaction Network Analysis Plot</h3>
<p>Protein-Protein Interaction Network Analysis (STRING) results plot,
filtered</p>
<p><img src="report_template_files/figure-html/string_filtered_analysis_plot%7D-1.png" width="672" /></p>
</div>
<div id="string-llm-agent-response" class="section level3">
<h3>8.3. STRING LLM Agent Response</h3>
<p>Agent 6: <strong>1. Summary of Interactions:</strong></p>
<p>The STRING analysis reveals a highly interconnected network of
proteins, with several exhibiting high combined network scores. Albumin
(ALB), a major plasma protein, shows strong interactions with multiple
proteins involved in immune response (e.g., CD68, FCGR1A, C1QA), lipid
metabolism (APOE, LPL), and extracellular matrix (ECM) components (ACAN,
COL1A1). Other highly connected proteins include PRKACB (protein kinase
A catalytic subunit beta), a key enzyme in various signaling pathways,
and CD68 (a macrophage marker) with connections to immune and complement
system components. These interactions suggest a complex interplay
between inflammation, lipid metabolism, and ECM remodeling in Behcet’s
disease.</p>
<p><strong>2. Key Interactions and Network Topology:</strong></p>
<p>Based on the combined network scores, ALB, PRKACB, CD68, CXCL1, APOE,
CX3CR1, and PXDNL stand out as key proteins. ALB’s extensive
interactions highlight its central role in the network, potentially
reflecting its involvement in multiple disease processes. PRKACB’s
numerous interactions suggest its importance in various signaling
pathways. CD68, a marker of macrophages, is highly connected to immune
and complement components, indicating macrophage activation. CXCL1
(chemokine ligand 5), CX3CR1 (chemokine receptor 1), and APOE
(apolipoprotein E) are involved in immune cell recruitment and lipid
metabolism. PXDNL (paxillin) is involved in cell adhesion and
cytoskeletal organization.</p>
<p>The network structure appears modular, with several clusters of
highly interconnected proteins. The complement system proteins (C1QA,
C1QB, C1QC) form a tightly connected cluster, as do several chemokines
and their receptors (CXCL1, CXCL5, CXCL16, CX3CR1, CXCR1, CXCR2, CCR8,
CCR9, XCR1, CCL4L1, CCL4L2, CCL14). ALB acts as a central hub,
connecting these modules. This modularity suggests that distinct
biological processes are coordinated to contribute to the overall
disease phenotype.</p>
<p><strong>4. Cross-Analysis:</strong></p>
<p>Several connections exist between the high-scoring proteins and the
enriched pathways. ALB is present in pathways related to complement and
coagulation cascades, lipid metabolism, and ECM-receptor interaction.
PRKACB is involved in multiple pathways, including chemokine signaling,
circadian entrainment, taste transduction, and various GPCR signaling
pathways. CD68 is involved in efferocytosis and immune response
pathways. CXCL1, CXCL5, CXCL16, CX3CR1, CXCR1, CXCR2, CCR8, CCR9, XCR1,
CCL4L1, CCL4L2, and CCL14 are all involved in cytokine-cytokine receptor
interaction and chemokine signaling pathways.</p>
<p>RELB, identified in the ChEA analysis, regulates several genes also
present in the interaction network (e.g., TNFAIP3, CXCL1, CXCL5, SOCS3).
This suggests that RELB could be a key upstream regulator of the
observed interactions.</p>
</div>
</div>
<div id="full-integrated-network" class="section level2">
<h2>9. Full Integrated Network</h2>
<p>The system representation from each of the 6 agents enrichment
analysis responses are integrated to build the below network. This is
the network that was used for deciphering the system model.</p>
<div class="visNetwork html-widget html-fill-item" id="htmlwidget-21d02c37b1ac9d055e3e" style="width:768px;height:576px;"></div>
<script type="application/json" data-for="htmlwidget-21d02c37b1ac9d055e3e">{"x":{"nodes":{"id":["ALB","CX3CR1","C1QA","GRIN1","RELB","CD68","CXCL1","APOE","COL1A1","TYROBP","SPI1","VTN","PRKACB","CEBPB","FOSL1","CXCL16","TLR3","FASLG","RBFOX3","C1QB","FCGR1A","PXDNL","CXCR2","GNG13","SOCS3","SYN1","C1QC","CXCL5","CXCR1","Complement Activation","Blood Vessel Diameter Maintenance","ECM-Receptor Interaction","Lipid Particles Composition","Chemokine-Mediated Signaling Pathway","Chemokine Signaling Pathway","Chemotaxis","Cytokine-Cytokine Receptor Interaction","Viral Protein Interaction With Cytokine And Cytokine Receptor","GPCRs Class A Rhodopsin Like","Complement System In Neuronal Development And Plasticity","Complement Cascade","Immune Response","Efferocytosis","Complement And Coagulation Cascades","Dengue 2 Interactions With Complement And Coagulation Cascades","Microglia Pathogen Phagocytosis Pathway","Oxidative Damage Response","Excitatory Chemical Synaptic Transmission","Positive Regulation Of MAPK Cascade","IL-17 Signaling Pathway","TNFAIP3","Osteoclast Differentiation","Osteoarthritic Chondrocyte Hypertrophy","Macrophage Activation","Response To Molecule Of Bacterial Origin","Positive Regulation Of Vascular Permeability","Lipoprotein Remodeling","Statin Inhibition Of Cholesterol Production","ECM Proteoglycans","Bone Development","Ecm Proteoglycans","Myeloid Leukocyte Activation","Apoptotic Cell Clearance","Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell","Animal Organ Regeneration","Syndecan Interactions","Non-Integrin Membrane-ECM Interactions","Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway","Circadian Entrainment","Taste Transduction","Chemokine Receptors Bind Chemokines","Glial Cell Activation","Splicing Factor Nova Regulated Synaptic Proteins","G Alpha (q) Signalling Events","G Alpha (s) Signalling Events","G Alpha (i) Signalling Events","Class C/3 (Metabotropic Glutamate/Pheromone Receptors)","Vasopressin Regulates Renal Water Homeostasis Via Aquaporins","GPCR Ligand Binding","Sensory Perception Of Taste","Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste","Synaptic Vesicle Pathway"],"group":["Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Gene","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Gene","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process","Process"],"label":["ALB","CX3CR1","C1QA","GRIN1","RELB","CD68","CXCL1","APOE","COL1A1","TYROBP","SPI1","VTN","PRKACB","CEBPB","FOSL1","CXCL16","TLR3","FASLG","RBFOX3","C1QB","FCGR1A","PXDNL","CXCR2","GNG13","SOCS3","SYN1","C1QC","CXCL5","CXCR1","Complement Activation","Blood Vessel Diameter Maintenance","ECM-Receptor Interaction","Lipid Particles Composition","Chemokine-Mediated Signaling Pathway","Chemokine Signaling Pathway","Chemotaxis","Cytokine-Cytokine Receptor Interaction","Viral Protein Interaction With Cytokine And Cytokine Receptor","GPCRs Class A Rhodopsin Like","Complement System In Neuronal Development And Plasticity","Complement Cascade","Immune Response","Efferocytosis","Complement And Coagulation Cascades","Dengue 2 Interactions With Complement And Coagulation Cascades","Microglia Pathogen Phagocytosis Pathway","Oxidative Damage Response","Excitatory Chemical Synaptic Transmission","Positive Regulation Of MAPK Cascade","IL-17 Signaling Pathway","TNFAIP3","Osteoclast Differentiation","Osteoarthritic Chondrocyte Hypertrophy","Macrophage Activation","Response To Molecule Of Bacterial Origin","Positive Regulation Of Vascular Permeability","Lipoprotein Remodeling","Statin Inhibition Of Cholesterol Production","ECM Proteoglycans","Bone Development","Ecm Proteoglycans","Myeloid Leukocyte Activation","Apoptotic Cell Clearance","Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell","Animal Organ Regeneration","Syndecan Interactions","Non-Integrin Membrane-ECM Interactions","Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway","Circadian Entrainment","Taste Transduction","Chemokine Receptors Bind Chemokines","Glial Cell Activation","Splicing Factor Nova Regulated Synaptic Proteins","G Alpha (q) Signalling Events","G Alpha (s) Signalling Events","G Alpha (i) Signalling Events","Class C/3 (Metabotropic Glutamate/Pheromone Receptors)","Vasopressin Regulates Renal Water Homeostasis Via Aquaporins","GPCR Ligand Binding","Sensory Perception Of Taste","Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste","Synaptic Vesicle Pathway"]},"edges":{"from":["ALB","ALB","ALB","ALB","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","GRIN1","RELB","RELB","RELB","RELB","RELB","RELB","RELB","RELB","RELB","RELB","RELB","RELB","CD68","CD68","CD68","CD68","CXCL1","CXCL1","CXCL1","CXCL1","APOE","APOE","APOE","APOE","APOE","APOE","COL1A1","COL1A1","COL1A1","COL1A1","TYROBP","TYROBP","TYROBP","TYROBP","TYROBP","SPI1","SPI1","VTN","VTN","VTN","VTN","VTN","VTN","VTN","PRKACB","PRKACB","PRKACB","PRKACB","CEBPB","CEBPB","CEBPB","CEBPB","CEBPB","CEBPB","FOSL1","CXCL16","CXCL16","CXCL16","CXCL16","TLR3","TLR3","FASLG","FASLG","RBFOX3","C1QB","C1QB","C1QB","C1QB","C1QB","C1QB","C1QB","C1QB","FCGR1A","FCGR1A","FCGR1A","PXDNL","CXCR2","CXCR2","CXCR2","CXCR2","CXCR2","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","GNG13","SOCS3","SOCS3","SYN1","SYN1","C1QC","C1QC","C1QC","C1QC","C1QC","C1QC","C1QC","C1QC","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","ALB","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","CX3CR1","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","C1QA","C1QB","C1QB","C1QB","C1QB","C1QB","C1QC","C1QC","C1QC","C1QC","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL1","CXCL5","CXCL5","CXCL5","CXCL5","CXCR1","CXCR1","CXCR1","CXCR2","VTN","VTN","VTN","APOE","APOE","APOE","APOE","APOE","APOE","APOE","SPI1","SPI1","SPI1","SPI1","SPI1","SPI1","SPI1","TYROBP","TYROBP","TYROBP","TYROBP","TYROBP","TYROBP","TYROBP","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CD68","CEBPB","CEBPB","CEBPB","CEBPB","CEBPB","COL1A1","COL1A1","COL1A1","COL1A1","COL1A1","GRIN1","GRIN1","RELB","RELB","RELB","RELB","SOCS3","SOCS3","SOCS3","SOCS3","PXDNL","PXDNL","PXDNL","PXDNL","PXDNL","PXDNL","PXDNL","PXDNL","PRKACB","PRKACB","PRKACB","SYN1","SYN1","SYN1","SYN1","TLR3","TLR3","TLR3","TLR3","TLR3","TLR3","TLR3","FASLG","FASLG","FASLG"],"to":["Complement Activation","Blood Vessel Diameter Maintenance","ECM-Receptor Interaction","Lipid Particles Composition","Chemokine-Mediated Signaling Pathway","Chemokine Signaling Pathway","Chemotaxis","Cytokine-Cytokine Receptor Interaction","Viral Protein Interaction With Cytokine And Cytokine Receptor","GPCRs Class A Rhodopsin Like","Complement System In Neuronal Development And Plasticity","Complement Activation","Complement Cascade","Immune Response","Efferocytosis","Complement And Coagulation Cascades","Dengue 2 Interactions With Complement And Coagulation Cascades","Microglia Pathogen Phagocytosis Pathway","Oxidative Damage Response","Complement System In Neuronal Development And Plasticity","Excitatory Chemical Synaptic Transmission","Positive Regulation Of MAPK Cascade","RELB","Cytokine-Cytokine Receptor Interaction","Chemokine Signaling Pathway","IL-17 Signaling Pathway","Complement And Coagulation Cascades","CXCL1","CXCL5","TNFAIP3","Immune Response","Osteoclast Differentiation","Osteoarthritic Chondrocyte Hypertrophy","Macrophage Activation","Response To Molecule Of Bacterial Origin","Efferocytosis","Microglia Pathogen Phagocytosis Pathway","Chemokine-Mediated Signaling Pathway","Chemotaxis","Cytokine-Cytokine Receptor Interaction","Chemokine Signaling Pathway","Positive Regulation Of Vascular Permeability","Lipoprotein Remodeling","Complement Cascade","Blood Vessel Diameter Maintenance","Lipid Particles Composition","Statin Inhibition Of Cholesterol Production","ECM-Receptor Interaction","ECM Proteoglycans","Bone Development","Ecm Proteoglycans","Myeloid Leukocyte Activation","Apoptotic Cell Clearance","Osteoclast Differentiation","Microglia Pathogen Phagocytosis Pathway","Immunoregulatory Interactions Between A Lymphoid And A Non-Lymphoid Cell","Myeloid Leukocyte Activation","Osteoclast Differentiation","Complement And Coagulation Cascades","ECM-Receptor Interaction","Animal Organ Regeneration","Syndecan Interactions","Non-Integrin Membrane-ECM Interactions","ECM Proteoglycans","Complement System In Neuronal Development And Plasticity","Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway","Chemokine Signaling Pathway","Circadian Entrainment","Taste Transduction","IL-17 Signaling Pathway","Animal Organ Regeneration","Osteoclast Differentiation","Efferocytosis","Complement And Coagulation Cascades","RELB","IL-17 Signaling Pathway","Cytokine-Cytokine Receptor Interaction","Chemokine Signaling Pathway","GPCRs Class A Rhodopsin Like","Chemokine Receptors Bind Chemokines","Glial Cell Activation","Myeloid Leukocyte Activation","Cytokine-Cytokine Receptor Interaction","Complement System In Neuronal Development And Plasticity","Splicing Factor Nova Regulated Synaptic Proteins","Complement Activation","Complement Cascade","Efferocytosis","Complement And Coagulation Cascades","Dengue 2 Interactions With Complement And Coagulation Cascades","Microglia Pathogen Phagocytosis Pathway","Oxidative Damage Response","Complement System In Neuronal Development And Plasticity","Immune Response","Myeloid Leukocyte Activation","Microglia Pathogen Phagocytosis Pathway","RELB","Chemotaxis","Cytokine-Cytokine Receptor Interaction","Viral Protein Interaction With Cytokine And Cytokine Receptor","Chemokine Signaling Pathway","GPCRs Class A Rhodopsin Like","Chemokine Signaling Pathway","Circadian Entrainment","Taste Transduction","GPCRs Class A Rhodopsin Like","G Alpha (q) Signalling Events","G Alpha (s) Signalling Events","G Alpha (i) Signalling Events","Class C/3 (Metabotropic Glutamate/Pheromone Receptors)","Vasopressin Regulates Renal Water Homeostasis Via Aquaporins","GPCR Ligand Binding","Sensory Perception Of Taste","Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste","Osteoclast Differentiation","RELB","Synaptic Vesicle Pathway","Splicing Factor Nova Regulated Synaptic Proteins","Complement Activation","Complement Cascade","Efferocytosis","Complement And Coagulation Cascades","Dengue 2 Interactions With Complement And Coagulation Cascades","Microglia Pathogen Phagocytosis Pathway","Oxidative Damage Response","Complement System In Neuronal Development And Plasticity","VTN","APOE","PXDNL","PRKACB","COL1A1","CD68","CXCL1","CX3CR1","FCGR1A","SYN1","RBFOX3","TLR3","FASLG","CXCL1","CXCL16","FCGR1A","RBFOX3","FASLG","C1QA","CXCR1","CXCR2","C1QB","C1QC","TYROBP","FCGR1A","APOE","CD68","SPI1","C1QC","TYROBP","APOE","CD68","FCGR1A","TYROBP","APOE","CD68","FCGR1A","CXCL5","CXCL16","CXCR1","CXCR2","CX3CR1","TNFAIP3","SOCS3","FASLG","TLR3","PXDNL","CXCR1","CXCR2","CXCL16","CX3CR1","CXCR2","CXCL16","FCGR1A","CX3CR1","APOE","ALB","PXDNL","TYROBP","CD68","C1QA","C1QB","C1QC","PRKACB","PXDNL","TYROBP","FCGR1A","CEBPB","C1QA","C1QC","CX3CR1","CD68","C1QA","C1QB","C1QC","FCGR1A","APOE","CD68","CX3CR1","APOE","TYROBP","PXDNL","C1QA","C1QB","C1QC","CXCL1","CXCL16","FCGR1A","RBFOX3","CX3CR1","TLR3","CXCR2","SOCS3","FOSL1","SPI1","CXCL1","SOCS3","PXDNL","APOE","ALB","CD68","PXDNL","CXCR2","SYN1","RBFOX3","TLR3","CEBPB","PXDNL","SPI1","PXDNL","CXCL1","CEBPB","TLR3","FASLG","PRKACB","CXCL1","RBFOX3","CD68","APOE","VTN","ALB","GRIN1","GNG13","APOE","RBFOX3","GRIN1","PXDNL","PRKACB","FASLG","CXCL1","SOCS3","RELB","CX3CR1","CD68","ALB","CXCL1","PXDNL","CX3CR1"]},"nodesToDataframe":true,"edgesToDataframe":true,"options":{"width":"100%","height":"100%","nodes":{"shape":"dot","size":20,"font":{"size":24}},"manipulation":{"enabled":false},"edges":{"arrows":"to"}},"groups":["Gene","Process"],"width":null,"height":null,"idselection":{"enabled":false,"style":"width: 150px; height: 26px","useLabels":true,"main":"Select by id"},"byselection":{"enabled":false,"style":"width: 150px; height: 26px","multiple":false,"hideColor":"rgba(200,200,200,0.5)","highlight":false},"main":null,"submain":null,"footer":null,"background":"rgba(0, 0, 0, 0)","highlight":{"enabled":true,"hoverNearest":false,"degree":1,"algorithm":"all","hideColor":"rgba(200,200,200,0.5)","labelOnly":true},"collapse":{"enabled":false,"fit":false,"resetHighlight":true,"clusterOptions":null,"keepCoord":true,"labelSuffix":"(cluster)"}},"evals":[],"jsHooks":[]}</script>
</div>
<div id="download" class="section level2">
<h2>10. Download</h2>
<p>Here is the list of all original results, along with filtered
results, computed results, integrated results and LLM responses:</p>
<p><a href='enrichment_results/system_model.txt'>Click to open
system_model.txt in new tab</a>
<br><a href='enrichment_results/final_response.txt'>Click to open
final_response.txt in new tab</a>
<br><a href='enrichment_results/agent_responses.txt'>Click to open
agent_responses.txt in new tab</a>
<br><a href='enrichment_results/kegg_enrichment_original.txt'>Click to
open kegg_enrichment_original.txt in new tab</a>
<br><a href='enrichment_results/kegg_enrichment_filtered.txt'>Click to
open kegg_enrichment_filtered.txt in new tab</a>
<br><a href='enrichment_results/wp_enrichment_original.txt'>Click to
open wp_enrichment_original.txt in new tab</a>
<br><a href='enrichment_results/wp_enrichment_filtered.txt'>Click to
open wp_enrichment_filtered.txt in new tab</a>
<br><a href='enrichment_results/reactome_enrichment_original.txt'>Click
to open reactome_enrichment_original.txt in new tab</a>
<br><a href='enrichment_results/reactome_enrichment_filtered.txt'>Click
to open reactome_enrichment_filtered.txt in new tab</a>
<br><a href='enrichment_results/chea_enrichment_original.txt'>Click to
open chea_enrichment_original.txt in new tab</a>
<br><a href='enrichment_results/chea_enrichment_filtered.txt'>Click to
open chea_enrichment_filtered.txt in new tab</a>
<br><a href='enrichment_results/string_interactions_original.txt'>Click
to open string_interactions_original.txt in new tab</a>
<br><a href='enrichment_results/string_interactions_filtered.txt'>Click
to open string_interactions_filtered.txt in new tab</a>
<br><a href='enrichment_results/string_network_properties.txt'>Click to
open string_network_properties.txt in new tab</a>
<br><a href='enrichment_results/pathway_comparison.txt'>Click to open
pathway_comparison.txt in new tab</a>
<br><a href='enrichment_results/integrated_network.txt'>Click to open
integrated_network.txt in new tab</a> <br></p>
</div>
<div id="analysis-parameters" class="section level2">
<h2>11. Analysis Parameters</h2>
<p>The following parameters were used for this analysis:</p>
<pre><code>## [1] &quot;Experimental Design:&quot;</code></pre>
<pre><code>## Peripheral blood samples were collected from 9 BD (Behcet’s disease) patients who fulfilled the 2013 International Criteria for BD and 10 HC (healthy controls). Total RNA was extracted from PBMCs and used for generating the RNA-Seq data. DESEq was used to identify differentially expressed genes between BD and HC samples</code></pre>
<table>
<caption>
Analysis Parameters
</caption>
<thead>
<tr>
<th style="text-align:left;">
Parameter
</th>
<th style="text-align:left;">
Value
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
gene_type
</td>
<td style="text-align:left;">
ENSEMBL
</td>
</tr>
<tr>
<td style="text-align:left;">
organism
</td>
<td style="text-align:left;">
human
</td>
</tr>
<tr>
<td style="text-align:left;">
input_type
</td>
<td style="text-align:left;">
deseq
</td>
</tr>
<tr>
<td style="text-align:left;">
deg_file
</td>
<td style="text-align:left;">
/Users/nagarajanv/OneDrive - National Institutes of
Health/Research/smart-enrichment/Ian/Ian/data/uveitis-PIIS0002939421000271-deg.txt
</td>
</tr>
<tr>
<td style="text-align:left;">
pvalue
</td>
<td style="text-align:left;">
0.05
</td>
</tr>
<tr>
<td style="text-align:left;">
ont
</td>
<td style="text-align:left;">
BP
</td>
</tr>
<tr>
<td style="text-align:left;">
score_threshold
</td>
<td style="text-align:left;">
0
</td>
</tr>
</tbody>
</table>
</div>
<div id="session-info" class="section level2">
<h2>12. Session Info</h2>
<pre><code>## R version 4.4.1 (2024-06-14)
## Platform: aarch64-apple-darwin20
## Running under: macOS Ventura 13.7.3
## 
## Matrix products: default
## BLAS:   /System/Library/Frameworks/Accelerate.framework/Versions/A/Frameworks/vecLib.framework/Versions/A/libBLAS.dylib 
## LAPACK: /Library/Frameworks/R.framework/Versions/4.4-arm64/Resources/lib/libRlapack.dylib;  LAPACK version 3.12.0
## 
## locale:
## [1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8
## 
## time zone: America/New_York
## tzcode source: internal
## 
## attached base packages:
## [1] stats4    stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
##  [1] ggh4x_0.3.0                 knitr_1.48                  lubridate_1.9.3            
##  [4] forcats_1.0.0               purrr_1.0.2                 tidyr_1.3.1                
##  [7] tibble_3.2.1                ggplot2_3.5.1               tidyverse_2.0.0            
## [10] openxlsx_4.2.7.1            rmarkdown_2.27              DESeq2_1.44.0              
## [13] SummarizedExperiment_1.34.0 MatrixGenerics_1.16.0       matrixStats_1.3.0          
## [16] GenomicRanges_1.56.1        GenomeInfoDb_1.40.1         kableExtra_1.4.0           
## [19] progressr_0.14.0            visNetwork_2.1.2            igraph_2.0.3               
## [22] STRINGdb_2.16.4             org.Hs.eg.db_3.19.1         AnnotationDbi_1.66.0       
## [25] IRanges_2.38.1              S4Vectors_0.42.1            Biobase_2.64.0             
## [28] BiocGenerics_0.50.0         enrichR_3.2                 ReactomePA_1.48.0          
## [31] clusterProfiler_4.12.6      readr_2.1.5                 R6_2.5.1                   
## [34] httr_1.4.7                  stringr_1.5.1               plyr_1.8.9                 
## [37] dplyr_1.1.4                 furrr_0.3.1                 future_1.34.0              
## 
## loaded via a namespace (and not attached):
##   [1] fs_1.6.4                bitops_1.0-7            enrichplot_1.24.4       devtools_2.4.5         
##   [5] RColorBrewer_1.1-3      numDeriv_2016.8-1.1     profvis_0.3.8           tools_4.4.1            
##   [9] utf8_1.2.4              lazyeval_0.2.2          apeglm_1.26.1           urlchecker_1.0.1       
##  [13] withr_3.0.0             graphite_1.50.0         gridExtra_2.3           textshaping_0.4.0      
##  [17] cli_3.6.3               scatterpie_0.2.4        labeling_0.4.3          sass_0.4.9             
##  [21] mvtnorm_1.2-5           systemfonts_1.1.0       yulab.utils_0.1.7       gson_0.1.0             
##  [25] DOSE_3.30.5             svglite_2.1.3           R.utils_2.12.3          parallelly_1.38.0      
##  [29] WriteXLS_6.6.0          sessioninfo_1.2.2       plotrix_3.8-4           bbmle_1.0.25.1         
##  [33] rstudioapi_0.16.0       RSQLite_2.3.7           generics_0.1.3          gridGraphics_0.5-1     
##  [37] vroom_1.6.5             gtools_3.9.5            zip_2.3.1               GO.db_3.19.1           
##  [41] Matrix_1.7-0            fansi_1.0.6             abind_1.4-5             R.methodsS3_1.8.2      
##  [45] lifecycle_1.0.4         yaml_2.3.9              gplots_3.1.3.1          qvalue_2.36.0          
##  [49] SparseArray_1.4.8       grid_4.4.1              blob_1.2.4              promises_1.3.0         
##  [53] crayon_1.5.3            bdsmatrix_1.3-7         miniUI_0.1.1.1          lattice_0.22-6         
##  [57] cowplot_1.1.3           KEGGREST_1.44.1         pillar_1.9.0            fgsea_1.30.0           
##  [61] rjson_0.2.21            codetools_0.2-20        fastmatch_1.1-4         glue_1.7.0             
##  [65] ggfun_0.1.5             data.table_1.15.4       remotes_2.5.0           vctrs_0.6.5            
##  [69] png_0.1-8               treeio_1.28.0           gtable_0.3.5            gsubfn_0.7             
##  [73] emdbook_1.3.13          cachem_1.1.0            xfun_0.45               S4Arrays_1.4.1         
##  [77] mime_0.12               tidygraph_1.3.1         coda_0.19-4.1           ellipsis_0.3.2         
##  [81] nlme_3.1-164            ggtree_3.12.0           usethis_3.0.0           bit64_4.0.5            
##  [85] bslib_0.7.0             KernSmooth_2.23-24      colorspace_2.1-0        DBI_1.2.3              
##  [89] tidyselect_1.2.1        bit_4.0.5               compiler_4.4.1          curl_6.0.1             
##  [93] chron_2.3-61            httr2_1.0.1             graph_1.82.0            xml2_1.3.6             
##  [97] DelayedArray_0.30.1     shadowtext_0.1.4        scales_1.3.0            caTools_1.18.2         
## [101] rappdirs_0.3.3          digest_0.6.36           XVector_0.44.0          htmltools_0.5.8.1      
## [105] pkgconfig_2.0.3         highr_0.11              fastmap_1.2.0           rlang_1.1.4            
## [109] htmlwidgets_1.6.4       UCSC.utils_1.0.0        shiny_1.8.1.1           farver_2.1.2           
## [113] jquerylib_0.1.4         jsonlite_1.8.8          BiocParallel_1.38.0     GOSemSim_2.30.2        
## [117] R.oo_1.26.0             magrittr_2.0.3          GenomeInfoDbData_1.2.12 ggplotify_0.1.2        
## [121] patchwork_1.2.0         munsell_0.5.1           Rcpp_1.0.12             ape_5.8                
## [125] viridis_0.6.5           proto_1.0.0             sqldf_0.4-11            stringi_1.8.4          
## [129] ggraph_2.2.1            zlibbioc_1.50.0         MASS_7.3-60.2           pkgbuild_1.4.4         
## [133] parallel_4.4.1          listenv_0.9.1           ggrepel_0.9.5           Biostrings_2.72.1      
## [137] graphlayouts_1.2.0      splines_4.4.1           hash_2.2.6.3            hms_1.1.3              
## [141] locfit_1.5-9.10         reshape2_1.4.4          pkgload_1.4.0           evaluate_0.24.0        
## [145] BiocManager_1.30.23     tzdb_0.4.0              tweenr_2.0.3            httpuv_1.6.15          
## [149] polyclip_1.10-6         ggforce_0.4.2           xtable_1.8-4            reactome.db_1.88.0     
## [153] tidytree_0.4.6          later_1.3.2             ragg_1.3.2              viridisLite_0.4.2      
## [157] aplot_0.2.3             memoise_2.0.1           timechange_0.3.0        globals_0.16.3</code></pre>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
